{
    "abstract": "Seasonal and pandemic influenza infections remain a serious public health concern. Many health authorities recommend annual vaccination as the most effective way to control influenza infection. Accordingly, regulatory guidelines ask vaccine manufacturers to determine vaccine potency at the time of release and throughout shelf-life to ensure vaccine quality. The potency of inactivated influenza vaccine is related to the quantity of hemagglutinin (HA). Since 1970s, single radial immunodiffusion (SRID) assay has been standardly used for the quantitation of HA in influenza vaccine. However, SRID is labor-intensive, inaccurate, and requires standard reference reagents that should be updated annually. Therefore, there have been extensive efforts to develop alternative potency assays. In this study, we developed and tested a new HA quantitative enzyme-linked immunosorbent assay (ELISA) using a universal monoclonal antibody that can bind to HAs from various subtypes in group 1 influenza A virus (IAV). We analyzed the conserved stalk domain of HA via a library approach to design a consensus HA antigen for group 1 IAV. The antigens were expressed as a soluble form in E. coli and were purified by Ni-affinity chromatography. When tested with variety of HAs from IAVs or influenza B viruses (IBVs), the mAbs exhibited specific binding to group 1 HAs, with potential exception to H9 subtype. Among various conditions of pH, urea, and reducing agents, pretreatment of HA at low pH exposing the conserved stalk domain was crucially important for optimal ELISA performance. Calibration curves for various HAs were generated to determine accuracy, specificity, sensitivity, and linear dynamic range. The ELISA method shows high sensitivity and accuracy compared with the SRID assay. The HA group specific universal mAbs against the consensus stalk domain of HA are conducive to establishing an ELISA-based standard procedure for the quantitation of HA antigens for annual vaccination against influenza infection.",
    "author_highlights": [
        {
            "endOffset": 20993,
            "sentence": "We developed a novel HA quantitative ELISA as an alternative for SRID.",
            "startOffset": 20923
        },
        {
            "endOffset": 21056,
            "sentence": "The ELISA uses broadly reactive group-specific universal mAbs.",
            "startOffset": 20994
        },
        {
            "endOffset": 21110,
            "sentence": "The assay is less time-consuming than the SRID assay.",
            "startOffset": 21057
        },
        {
            "endOffset": 21185,
            "sentence": "The assay has good accuracy, specificity, sensitivity and reproducibility.",
            "startOffset": 21111
        },
        {
            "endOffset": 21259,
            "sentence": "The assay performs better than SRID in terms of accuracy and sensitivity.",
            "startOffset": 21186
        }
    ],
    "bib_entries": {
        "b0005": null,
        "b0010": {
            "authors": [
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Knossow"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Gaudier"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Douglas"
                },
                {
                    "first": "B.",
                    "initial": "B.",
                    "last": "Barr\u00e8re"
                },
                {
                    "first": "T.",
                    "initial": "T.",
                    "last": "Bizebard"
                },
                {
                    "first": "C.",
                    "initial": "C.",
                    "last": "Barbey"
                },
                {
                    "first": "B.",
                    "initial": "B.",
                    "last": "Gigant"
                },
                {
                    "first": "J. J.",
                    "initial": "J.J.",
                    "last": "Skehel"
                }
            ],
            "doi": "10.1006/viro.2002.1625",
            "firstpage": "294",
            "issn": "00426822",
            "lastpage": "298",
            "pmid": "12441073",
            "pub_year": 2002,
            "title": "Mechanism of neutralization of influenza virus infectivity by antibodies",
            "volume": "302"
        },
        "b0015": {
            "authors": [
                {
                    "first": "J. R.",
                    "initial": "J.R.",
                    "last": "La Montagne"
                },
                {
                    "first": "G. R.",
                    "initial": "G.R.",
                    "last": "Noble"
                },
                {
                    "first": "G. V.",
                    "initial": "G.V.",
                    "last": "Quinnan"
                },
                {
                    "first": "G. T.",
                    "initial": "G.T.",
                    "last": "Curlin"
                },
                {
                    "first": "W. C.",
                    "initial": "W.C.",
                    "last": "Blackwelder"
                },
                {
                    "first": "J. I.",
                    "initial": "J.I.",
                    "last": "Smith"
                },
                {
                    "first": "F. A.",
                    "initial": "F.A.",
                    "last": "Ennis"
                },
                {
                    "first": "F. M.",
                    "initial": "F.M.",
                    "last": "Bozeman"
                }
            ],
            "firstpage": "723",
            "issn": "01620886",
            "lastpage": "736",
            "pmid": "6353529",
            "pub_year": 1983,
            "title": "Summary of clinical trials of inactivated influenza vaccine - 1978.",
            "volume": "5"
        },
        "b0020": {
            "authors": [
                {
                    "first": "D.",
                    "initial": "D.",
                    "last": "Hobson"
                },
                {
                    "first": "R. L.",
                    "initial": "R.L.",
                    "last": "Curry"
                },
                {
                    "first": "A. S.",
                    "initial": "A.S.",
                    "last": "Beare"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Ward-Gardner"
                }
            ],
            "doi": "10.1017/S0022172400022610",
            "firstpage": "767",
            "issn": "00221724",
            "lastpage": "777",
            "pmid": "4509641",
            "pub_year": 1972,
            "title": "The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses",
            "volume": "70"
        },
        "b0025": {
            "authors": [
                {
                    "first": "M. S.",
                    "initial": "M.S.",
                    "last": "Williams"
                }
            ],
            "doi": "10.1016/0378-1135(93)90027-5",
            "firstpage": "253",
            "issn": "03781135",
            "lastpage": "262",
            "pmid": "8116186",
            "pub_year": 1993,
            "title": "Single-radial-immunodiffusion as an in vitro potency assay for human inactivated viral vaccines",
            "volume": "37"
        },
        "b0030": {
            "authors": [
                {
                    "first": "Stephanie",
                    "initial": "S.",
                    "last": "Hardy"
                },
                {
                    "first": "Maryna",
                    "initial": "M.",
                    "last": "Eichelberger"
                },
                {
                    "first": "Elwyn",
                    "initial": "E.",
                    "last": "Griffiths"
                },
                {
                    "first": "Jerry P.",
                    "initial": "J.P.",
                    "last": "Weir"
                },
                {
                    "first": "David",
                    "initial": "D.",
                    "last": "Wood"
                },
                {
                    "first": "Claudia",
                    "initial": "C.",
                    "last": "Alfonso"
                }
            ],
            "doi": "10.1111/j.1750-2659.2011.00250.x",
            "firstpage": "438",
            "issn": "17502640",
            "lastpage": "442",
            "pmid": "21668676",
            "pub_year": 2011,
            "title": "Confronting the next pandemic-Workshop on lessons learned from potency testing of pandemic (H1N1) 2009 influenza vaccines and considerations for future potency tests, Ottawa, Canada, July 27-29, 2010",
            "volume": "5"
        },
        "b0035": {
            "authors": [
                {
                    "first": "John M.",
                    "initial": "J.M.",
                    "last": "Wood"
                },
                {
                    "first": "Jerry P.",
                    "initial": "J.P.",
                    "last": "Weir"
                }
            ],
            "doi": "10.1111/irv.12543",
            "firstpage": "195",
            "issn": "17502640",
            "lastpage": "201",
            "pmid": "29356318",
            "pub_year": 2018,
            "title": "Standardisation of inactivated influenza vaccines\u2014Learning from history",
            "volume": "12"
        },
        "b0040": {
            "authors": [
                {
                    "first": "Young Seok",
                    "initial": "Y.S.",
                    "last": "Kim"
                },
                {
                    "first": "Ahyun",
                    "initial": "A.",
                    "last": "Son"
                },
                {
                    "first": "Jihoon",
                    "initial": "J.",
                    "last": "Kim"
                },
                {
                    "first": "Soon Bin",
                    "initial": "S.B.",
                    "last": "Kwon"
                },
                {
                    "first": "Myung Hee",
                    "initial": "M.H.",
                    "last": "Kim"
                },
                {
                    "first": "Paul",
                    "initial": "P.",
                    "last": "Kim"
                },
                {
                    "first": "Jieun",
                    "initial": "J.",
                    "last": "Kim"
                },
                {
                    "first": "Young Ho",
                    "initial": "Y.H.",
                    "last": "Byun"
                },
                {
                    "first": "Jemin",
                    "initial": "J.",
                    "last": "Sung"
                },
                {
                    "first": "Jinhee",
                    "initial": "J.",
                    "last": "Lee"
                },
                {
                    "first": "Ji Eun",
                    "initial": "J.E.",
                    "last": "Yu"
                },
                {
                    "first": "Chan",
                    "initial": "C.",
                    "last": "Park"
                },
                {
                    "first": "Yeon Sook",
                    "initial": "Y.S.",
                    "last": "Kim"
                },
                {
                    "first": "Nam Hyuk",
                    "initial": "N.H.",
                    "last": "Cho"
                },
                {
                    "first": "Jun",
                    "initial": "J.",
                    "last": "Chang"
                },
                {
                    "first": "Baik L.",
                    "initial": "B.L.",
                    "last": "Seong"
                }
            ],
            "doi": "10.3389/fimmu.2018.01093",
            "issn": "16643224",
            "pub_year": 2018,
            "title": "Chaperna-mediated assembly of ferritin-based middle East respiratory syndrome-coronavirus nanoparticles",
            "volume": "9"
        },
        "b0045": {
            "authors": [
                {
                    "first": "Seung Won",
                    "initial": "S.W.",
                    "last": "Yang"
                },
                {
                    "first": "Yo Han",
                    "initial": "Y.H.",
                    "last": "Jang"
                },
                {
                    "first": "Soon Bin",
                    "initial": "S.B.",
                    "last": "Kwon"
                },
                {
                    "first": "Yoon Jae",
                    "initial": "Y.J.",
                    "last": "Lee"
                },
                {
                    "first": "Wonil",
                    "initial": "W.",
                    "last": "Chae"
                },
                {
                    "first": "Young Ho",
                    "initial": "Y.H.",
                    "last": "Byun"
                },
                {
                    "first": "Paul",
                    "initial": "P.",
                    "last": "Kim"
                },
                {
                    "first": "Chan",
                    "initial": "C.",
                    "last": "Park"
                },
                {
                    "first": "Young Jae",
                    "initial": "Y.J.",
                    "last": "Lee"
                },
                {
                    "first": "Choon",
                    "initial": "C.",
                    "last": "Kang Kim"
                },
                {
                    "first": "Young Seok",
                    "initial": "Y.S.",
                    "last": "Kim"
                },
                {
                    "first": "Seong Il",
                    "initial": "S.I.",
                    "last": "Choi"
                },
                {
                    "first": "Baik Lin",
                    "initial": "B.L.",
                    "last": "Seong"
                }
            ],
            "doi": "10.1096/fj.201700747RR",
            "firstpage": "2658",
            "issn": "08926638",
            "lastpage": "2675",
            "pmid": "29295864",
            "pub_year": 2018,
            "title": "Harnessing an RNA-mediated chaperone for the assembly of influenza hemagglutinin in an immunologically relevant conformation",
            "volume": "32"
        },
        "b0050": {
            "authors": [
                {
                    "first": "Martin Christen Frolund",
                    "initial": "M.C.F.",
                    "last": "Thomsen"
                },
                {
                    "first": "Morten",
                    "initial": "M.",
                    "last": "Nielsen"
                }
            ],
            "doi": "10.1093/nar/gks469",
            "firstpage": "W281",
            "issn": "03051048",
            "lastpage": "W287",
            "pmid": "22638583",
            "pub_year": 2012,
            "title": "Seq2Logo: A method for construction and visualization of amino acid binding motifs and sequence profiles including sequence weighting, pseudo counts and two-sided representation of amino acid enrichment and depletion",
            "volume": "40"
        },
        "b0055": {
            "authors": [
                {
                    "first": "C.",
                    "initial": "C.",
                    "last": "Combet"
                },
                {
                    "first": "C.",
                    "initial": "C.",
                    "last": "Blanchet"
                },
                {
                    "first": "C.",
                    "initial": "C.",
                    "last": "Geourjon"
                },
                {
                    "first": "G.",
                    "initial": "G.",
                    "last": "Del\u00e9age"
                }
            ],
            "doi": "10.1016/S0968-0004(99)01540-6",
            "firstpage": "147",
            "issn": "09680004",
            "lastpage": "150",
            "pmid": "10694887",
            "pub_year": 2000,
            "title": "NPS@: Network protein sequence analysis",
            "volume": "25"
        },
        "b0060": {
            "authors": [
                {
                    "first": "Nicolas",
                    "initial": "N.",
                    "last": "Guex"
                },
                {
                    "first": "Manuel C.",
                    "initial": "M.C.",
                    "last": "Peitsch"
                },
                {
                    "first": "Torsten",
                    "initial": "T.",
                    "last": "Schwede"
                }
            ],
            "doi": "10.1002/elps.200900140",
            "firstpage": "S162",
            "issn": "01730835",
            "lastpage": "S173",
            "pmid": "19517507",
            "pub_year": 2009,
            "title": "Automated comparative protein structure modeling with SWISS-MODEL and Swiss-PdbViewer: A historical perspective",
            "volume": "30"
        },
        "b0065": {
            "authors": [
                {
                    "first": "Stephen R.",
                    "initial": "S.R.",
                    "last": "Comeau"
                },
                {
                    "first": "David W.",
                    "initial": "D.W.",
                    "last": "Gatchell"
                },
                {
                    "first": "Sandor",
                    "initial": "S.",
                    "last": "Vajda"
                },
                {
                    "first": "Carlos J.",
                    "initial": "C.J.",
                    "last": "Camacho"
                }
            ],
            "doi": "10.1093/nar/gkh354",
            "firstpage": "W96",
            "issn": "03051048",
            "lastpage": "W99",
            "pmid": "15215358",
            "pub_year": 2004,
            "title": "ClusPro: A fully automated algorithm for protein-protein docking",
            "volume": "32"
        },
        "b0070": {
            "authors": [
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Shrake"
                },
                {
                    "first": "J. A.",
                    "initial": "J.A.",
                    "last": "Rupley"
                }
            ],
            "doi": "10.1016/0022-2836(73)90011-9",
            "firstpage": "351",
            "issn": "00222836",
            "lastpage": "IN15",
            "pmid": "4760134",
            "pub_year": 1973,
            "title": "Environment and exposure to solvent of protein atoms. Lysozyme and insulin",
            "volume": "79"
        },
        "b0075": null,
        "b0080": null,
        "b0085": null,
        "b0090": {
            "authors": [
                {
                    "first": "Ruth E.",
                    "initial": "R.E.",
                    "last": "Soria-Guerra"
                },
                {
                    "first": "Ricardo",
                    "initial": "R.",
                    "last": "Nieto-Gomez"
                },
                {
                    "first": "Dania O.",
                    "initial": "D.O.",
                    "last": "Govea-Alonso"
                },
                {
                    "first": "Sergio",
                    "initial": "S.",
                    "last": "Rosales-Mendoza"
                }
            ],
            "doi": "10.1016/j.jbi.2014.11.003",
            "firstpage": "405",
            "issn": "15320464",
            "lastpage": "414",
            "pmid": "25464113",
            "pub_year": 2015,
            "title": "An overview of bioinformatics tools for epitope prediction: Implications on vaccine development",
            "volume": "53"
        },
        "b0095": {
            "authors": [
                {
                    "first": "Seong Il",
                    "initial": "S.I.",
                    "last": "Choi"
                },
                {
                    "first": "Kyoung Sim",
                    "initial": "K.S.",
                    "last": "Han"
                },
                {
                    "first": "Chul Woo",
                    "initial": "C.W.",
                    "last": "Kim"
                },
                {
                    "first": "Ki Sun",
                    "initial": "K.S.",
                    "last": "Ryu"
                },
                {
                    "first": "Byung Hee",
                    "initial": "B.H.",
                    "last": "Kim"
                },
                {
                    "first": "Kyun Hwan",
                    "initial": "K.H.",
                    "last": "Kim"
                },
                {
                    "first": "Seo Il",
                    "initial": "S.I.",
                    "last": "Kim"
                },
                {
                    "first": "Tae Hyun",
                    "initial": "T.H.",
                    "last": "Kang"
                },
                {
                    "first": "Hang Cheol",
                    "initial": "H.C.",
                    "last": "Shin"
                },
                {
                    "first": "Keo Heun",
                    "initial": "K.H.",
                    "last": "Lim"
                },
                {
                    "first": "Hyo Kyung",
                    "initial": "H.K.",
                    "last": "Kim"
                },
                {
                    "first": "Jeong Min",
                    "initial": "J.M.",
                    "last": "Hyun"
                },
                {
                    "first": "Baik L.",
                    "initial": "B.L.",
                    "last": "Seong"
                }
            ],
            "doi": "10.1371/journal.pone.0002677",
            "issn": "19326203",
            "pmid": "18628952",
            "pub_year": 2008,
            "title": "Protein solubility and folding enhancement by interaction with RNA",
            "volume": "3"
        },
        "b0100": {
            "authors": [
                {
                    "first": "Andrea",
                    "initial": "A.",
                    "last": "Vera"
                },
                {
                    "first": "Nuria",
                    "initial": "N.",
                    "last": "Gonz\u00e1lez-Montalb\u00e1n"
                },
                {
                    "first": "Anna",
                    "initial": "A.",
                    "last": "Ar\u00eds"
                },
                {
                    "first": "Antonio",
                    "initial": "A.",
                    "last": "Villaverde"
                }
            ],
            "doi": "10.1002/bit.21218",
            "firstpage": "1101",
            "issn": "00063592",
            "lastpage": "1106",
            "pmid": "17013944",
            "pub_year": 2007,
            "title": "The conformational quality of insoluble recombinant proteins is enhanced at low growth temperatures",
            "volume": "96"
        },
        "b0105": {
            "authors": [
                {
                    "first": "J. J.",
                    "initial": "J.J.",
                    "last": "Skehel"
                },
                {
                    "first": "M. D.",
                    "initial": "M.D.",
                    "last": "Waterfield"
                }
            ],
            "doi": "10.1073/pnas.72.1.93",
            "firstpage": "93",
            "issn": "00278424",
            "lastpage": "97",
            "pmid": "1054518",
            "pub_year": 1975,
            "title": "Studies on the primary structure of the influenza virus hemagglutinin",
            "volume": "72"
        },
        "b0110": {
            "authors": [
                {
                    "first": "Stephen C.",
                    "initial": "S.C.",
                    "last": "Harrison"
                }
            ],
            "doi": "10.1038/nsmb.1456",
            "firstpage": "690",
            "issn": "15459993",
            "lastpage": "698",
            "pmid": "18596815",
            "pub_year": 2008,
            "title": "Viral membrane fusion",
            "volume": "15"
        },
        "b0115": {
            "authors": [
                {
                    "first": "Xishan",
                    "initial": "X.",
                    "last": "Lu"
                },
                {
                    "first": "Yi",
                    "initial": "Y.",
                    "last": "Shi"
                },
                {
                    "first": "Feng",
                    "initial": "F.",
                    "last": "Gao"
                },
                {
                    "first": "Haixia",
                    "initial": "H.",
                    "last": "Xiao"
                },
                {
                    "first": "Ming",
                    "initial": "M.",
                    "last": "Wang"
                },
                {
                    "first": "Jianxun",
                    "initial": "J.",
                    "last": "Qi"
                },
                {
                    "first": "George F.",
                    "initial": "G.F.",
                    "last": "Gao"
                }
            ],
            "doi": "10.1128/JVI.01606-12",
            "firstpage": "12861",
            "issn": "0022538X",
            "lastpage": "12870",
            "pmid": "22993148",
            "pub_year": 2012,
            "title": "Insights into avian influenza virus pathogenicity, the hemagglutinin precursor HA0 of subtype H16 has an alpha-helix structure in its cleavage site with inefficient HA1/HA2 cleavage",
            "volume": "86"
        },
        "b0120": {
            "authors": [
                {
                    "first": "Eugenia",
                    "initial": "E.",
                    "last": "Leikina"
                },
                {
                    "first": "Corinne",
                    "initial": "C.",
                    "last": "Ramos"
                },
                {
                    "first": "Ingrid",
                    "initial": "I.",
                    "last": "Markovic"
                },
                {
                    "first": "Joshua",
                    "initial": "J.",
                    "last": "Zimmerberg"
                },
                {
                    "first": "Leonid V.",
                    "initial": "L.V.",
                    "last": "Chernomordik"
                }
            ],
            "doi": "10.1093/emboj/cdf559",
            "firstpage": "5701",
            "issn": "02614189",
            "lastpage": "5710",
            "pmid": "12411488",
            "pub_year": 2002,
            "title": "Reversible stages of the low-pH-triggered conformational change in influenza virus hemagglutinin",
            "volume": "21"
        },
        "b0125": {
            "authors": [
                {
                    "first": "Ke",
                    "initial": "K.",
                    "last": "Congyu"
                },
                {
                    "first": "Sun",
                    "initial": "S.",
                    "last": "Wujuan"
                },
                {
                    "first": "Zhang",
                    "initial": "Z.",
                    "last": "Qunzheng"
                },
                {
                    "first": "Geng",
                    "initial": "G.",
                    "last": "Xindu"
                }
            ],
            "doi": "10.1002/bmc.2810",
            "firstpage": "433",
            "issn": "02693879",
            "lastpage": "439",
            "pmid": "23033217",
            "pub_year": 2013,
            "title": "Refolding of urea-denatured \u03b1-chymotrypsin by protein-folding liquid chromatography",
            "volume": "27"
        },
        "b0130": {
            "authors": [
                {
                    "first": "Jesse",
                    "initial": "J.",
                    "last": "Bodle"
                },
                {
                    "first": "Erin E.",
                    "initial": "E.E.",
                    "last": "Verity"
                },
                {
                    "first": "Chi",
                    "initial": "C.",
                    "last": "Ong"
                },
                {
                    "first": "Kirsten",
                    "initial": "K.",
                    "last": "Vandenberg"
                },
                {
                    "first": "Robert",
                    "initial": "R.",
                    "last": "Shaw"
                },
                {
                    "first": "Ian G.",
                    "initial": "I.G.",
                    "last": "Barr"
                },
                {
                    "first": "Steven",
                    "initial": "S.",
                    "last": "Rockman"
                }
            ],
            "doi": "10.1111/j.1750-2659.2012.00375.x",
            "firstpage": "191",
            "issn": "17502640",
            "lastpage": "200",
            "pmid": "22583601",
            "pub_year": 2013,
            "title": "Development of an enzyme-linked immunoassay for the quantitation of influenza haemagglutinin: An alternative method to single radial immunodiffusion",
            "volume": "7"
        },
        "b0135": {
            "authors": [
                {
                    "first": "Falko",
                    "initial": "F.",
                    "last": "Schmeisser"
                },
                {
                    "first": "Anupama",
                    "initial": "A.",
                    "last": "Vasudevan"
                },
                {
                    "first": "Jackeline",
                    "initial": "J.",
                    "last": "Soto"
                },
                {
                    "first": "Arunima",
                    "initial": "A.",
                    "last": "Kumar"
                },
                {
                    "first": "Ollie",
                    "initial": "O.",
                    "last": "Williams"
                },
                {
                    "first": "Jerry P.",
                    "initial": "J.P.",
                    "last": "Weir"
                }
            ],
            "doi": "10.1111/irv.12272",
            "firstpage": "587",
            "issn": "17502640",
            "lastpage": "595",
            "pmid": "25087462",
            "pub_year": 2014,
            "title": "A monoclonal antibody-based immunoassay for measuring the potency of 2009 pandemic influenza H1N1 vaccines",
            "volume": "8"
        },
        "b0140": {
            "authors": [
                {
                    "first": "Caroline",
                    "initial": "C.",
                    "last": "Gravel"
                },
                {
                    "first": "Cathie",
                    "initial": "C.",
                    "last": "Elmgren"
                },
                {
                    "first": "Abenaya",
                    "initial": "A.",
                    "last": "Muralidharan"
                },
                {
                    "first": "Anwar M.",
                    "initial": "A.M.",
                    "last": "Hashem"
                },
                {
                    "first": "Bozena",
                    "initial": "B.",
                    "last": "Jaentschke"
                },
                {
                    "first": "Kangwei",
                    "initial": "K.",
                    "last": "Xu"
                },
                {
                    "first": "Jennifer",
                    "initial": "J.",
                    "last": "Widdison"
                },
                {
                    "first": "Kristin",
                    "initial": "K.",
                    "last": "Arnold"
                },
                {
                    "first": "Aaron",
                    "initial": "A.",
                    "last": "Farnsworth"
                },
                {
                    "first": "Aline",
                    "initial": "A.",
                    "last": "Rinfret"
                },
                {
                    "first": "Gary",
                    "initial": "G.",
                    "last": "Van Domselaar"
                },
                {
                    "first": "Junzhi",
                    "initial": "J.",
                    "last": "Wang"
                },
                {
                    "first": "Changgui",
                    "initial": "C.",
                    "last": "Li"
                },
                {
                    "first": "Xuguang",
                    "initial": "X.",
                    "last": "Li"
                }
            ],
            "doi": "10.1016/j.vaccine.2015.01.034",
            "firstpage": "1129",
            "issn": "0264410X",
            "lastpage": "1134",
            "pmid": "25620245",
            "pub_year": 2015,
            "title": "Development and applications of universal H7 subtype-specific antibodies for the analysis of influenza H7N9 vaccines",
            "volume": "33"
        },
        "b0145": {
            "authors": [
                {
                    "first": "Stella",
                    "initial": "S.",
                    "last": "Chun"
                },
                {
                    "first": "Changgui",
                    "initial": "C.",
                    "last": "Li"
                },
                {
                    "first": "Gary",
                    "initial": "G.",
                    "last": "Van Domselaar"
                },
                {
                    "first": "Junzhi",
                    "initial": "J.",
                    "last": "Wang"
                },
                {
                    "first": "Aaron",
                    "initial": "A.",
                    "last": "Farnsworth"
                },
                {
                    "first": "Xiaoyu",
                    "initial": "X.",
                    "last": "Cui"
                },
                {
                    "first": "Harold",
                    "initial": "H.",
                    "last": "Rode"
                },
                {
                    "first": "Terry D.",
                    "initial": "T.D.",
                    "last": "Cyr"
                },
                {
                    "first": "Runtao",
                    "initial": "R.",
                    "last": "He"
                },
                {
                    "first": "Xuguang",
                    "initial": "X.",
                    "last": "Li"
                }
            ],
            "doi": "10.1016/j.vaccine.2008.09.015",
            "firstpage": "6068",
            "issn": "0264410X",
            "lastpage": "6076",
            "pmid": "19007587",
            "pub_year": 2008,
            "title": "Universal antibodies and their applications to the quantitative determination of virtually all subtypes of the influenza A viral hemagglutinins",
            "volume": "26"
        },
        "b0150": {
            "authors": [
                {
                    "first": "Manika",
                    "initial": "M.",
                    "last": "Suryadevara"
                },
                {
                    "first": "Joseph B.",
                    "initial": "J.B.",
                    "last": "Domachowske"
                }
            ],
            "doi": "10.4161/hv.27115",
            "firstpage": "596",
            "issn": "21645515",
            "lastpage": "599",
            "pmid": "24231756",
            "pub_year": 2014,
            "title": "Quadrivalent influenza vaccine in the United States",
            "volume": "10"
        },
        "b0155": {
            "authors": [
                {
                    "first": "Gary J.",
                    "initial": "G.J.",
                    "last": "Nabel"
                },
                {
                    "first": "Chih Jen",
                    "initial": "C.J.",
                    "last": "Wei"
                },
                {
                    "first": "Julie E.",
                    "initial": "J.E.",
                    "last": "Ledgerwood"
                }
            ],
            "doi": "10.1038/471157a",
            "firstpage": "157",
            "issn": "00280836",
            "lastpage": "158",
            "pmid": "21390107",
            "pub_year": 2011,
            "title": "Vaccinate for the next H2N2 pandemic now",
            "volume": "471"
        },
        "b0160": {
            "authors": [
                {
                    "first": "Grace L.",
                    "initial": "G.L.",
                    "last": "Chen"
                },
                {
                    "first": "Elaine W.",
                    "initial": "E.W.",
                    "last": "Lamirande"
                },
                {
                    "first": "Chin Fen",
                    "initial": "C.F.",
                    "last": "Yang"
                },
                {
                    "first": "Hong",
                    "initial": "H.",
                    "last": "Jin"
                },
                {
                    "first": "George",
                    "initial": "G.",
                    "last": "Kemble"
                },
                {
                    "first": "Kanta",
                    "initial": "K.",
                    "last": "Subbarao"
                }
            ],
            "doi": "10.1128/JVI.00511-10",
            "firstpage": "7695",
            "issn": "0022538X",
            "lastpage": "7702",
            "pmid": "20504935",
            "pub_year": 2010,
            "title": "Evaluation of replication and cross-reactive antibody responses of H2 subtype influenza viruses in mice and ferrets",
            "volume": "84"
        },
        "b0165": {
            "authors": [
                {
                    "first": "Wenjun",
                    "initial": "W.",
                    "last": "Ma"
                },
                {
                    "first": "Amy L.",
                    "initial": "A.L.",
                    "last": "Vincent"
                },
                {
                    "first": "Marie R.",
                    "initial": "M.R.",
                    "last": "Gramer"
                },
                {
                    "first": "Christy B.",
                    "initial": "C.B.",
                    "last": "Brockwell"
                },
                {
                    "first": "Kelly M.",
                    "initial": "K.M.",
                    "last": "Lager"
                },
                {
                    "first": "Bruce H.",
                    "initial": "B.H.",
                    "last": "Janke"
                },
                {
                    "first": "Phillip C.",
                    "initial": "P.C.",
                    "last": "Gauger"
                },
                {
                    "first": "Devi P.",
                    "initial": "D.P.",
                    "last": "Patnayak"
                },
                {
                    "first": "Richard J.",
                    "initial": "R.J.",
                    "last": "Webby"
                },
                {
                    "first": "J\u00fcrgen A.",
                    "initial": "J.A.",
                    "last": "Richt"
                }
            ],
            "doi": "10.1073/pnas.0710286104",
            "firstpage": "20949",
            "issn": "00278424",
            "lastpage": "20954",
            "pmid": "18093945",
            "pub_year": 2007,
            "title": "Identification of H2N3 influenza A viruses from swine in the United States",
            "volume": "104"
        },
        "b0170": {
            "authors": [
                {
                    "first": "Jeremy C.",
                    "initial": "J.C.",
                    "last": "Jones"
                },
                {
                    "first": "Tatiana",
                    "initial": "T.",
                    "last": "Baranovich"
                },
                {
                    "first": "Bindumadhav M.",
                    "initial": "B.M.",
                    "last": "Marathe"
                },
                {
                    "first": "Angela F.",
                    "initial": "A.F.",
                    "last": "Danner"
                },
                {
                    "first": "Jon P.",
                    "initial": "J.P.",
                    "last": "Seiler"
                },
                {
                    "first": "John",
                    "initial": "J.",
                    "last": "Franks"
                },
                {
                    "first": "Elena A.",
                    "initial": "E.A.",
                    "last": "Govorkova"
                },
                {
                    "first": "Scott",
                    "initial": "S.",
                    "last": "Krauss"
                },
                {
                    "first": "Robert G.",
                    "initial": "R.G.",
                    "last": "Webster"
                }
            ],
            "doi": "10.1128/JVI.02526-13",
            "firstpage": "1175",
            "issn": "0022538X",
            "lastpage": "1188",
            "pmid": "24227848",
            "pub_year": 2014,
            "title": "Risk assessment of H2N2 influenza viruses from the avian reservoir",
            "volume": "88"
        },
        "b0175": {
            "authors": [
                {
                    "first": "Yong",
                    "initial": "Y.",
                    "last": "Poovorawan"
                },
                {
                    "first": "Sunchai",
                    "initial": "S.",
                    "last": "Pyungporn"
                },
                {
                    "first": "Slinporn",
                    "initial": "S.",
                    "last": "Prachayangprecha"
                },
                {
                    "first": "Jarika",
                    "initial": "J.",
                    "last": "Makkoch"
                }
            ],
            "doi": "10.1179/2047773213Y.0000000103",
            "firstpage": "217",
            "issn": "20477724",
            "lastpage": "223",
            "pub_year": 2013,
            "title": "Global alert to avian influenza virus infection: From H5N1 to H7N9",
            "volume": "107"
        },
        "b0180": {
            "authors": [
                {
                    "first": "Dennis J.",
                    "initial": "D.J.",
                    "last": "Alexander"
                }
            ],
            "doi": "10.1016/j.vaccine.2006.10.051",
            "firstpage": "5637",
            "issn": "0264410X",
            "lastpage": "5644",
            "pmid": "17126960",
            "pub_year": 2007,
            "title": "An overview of the epidemiology of avian influenza",
            "volume": "25"
        },
        "b0185": {
            "authors": [
                {
                    "first": "Yang",
                    "initial": "Y.",
                    "last": "Yang"
                },
                {
                    "first": "M. Elizabeth",
                    "initial": "M.E.",
                    "last": "Halloran"
                },
                {
                    "first": "Jonathan D.",
                    "initial": "J.D.",
                    "last": "Sugimoto"
                },
                {
                    "first": "Ira M.",
                    "initial": "I.M.",
                    "last": "Longini"
                }
            ],
            "doi": "10.3201/eid1309.070111",
            "firstpage": "1348",
            "issn": "10806040",
            "lastpage": "1353",
            "pmid": "18252106",
            "pub_year": 2007,
            "title": "Detecting human-to-human transmission of avian influenza A (H5N1)",
            "volume": "13"
        },
        "b0190": {
            "authors": [
                {
                    "first": "Masaki",
                    "initial": "M.",
                    "last": "Imai"
                },
                {
                    "first": "Tokiko",
                    "initial": "T.",
                    "last": "Watanabe"
                },
                {
                    "first": "Masato",
                    "initial": "M.",
                    "last": "Hatta"
                },
                {
                    "first": "Subash C.",
                    "initial": "S.C.",
                    "last": "Das"
                },
                {
                    "first": "Makoto",
                    "initial": "M.",
                    "last": "Ozawa"
                },
                {
                    "first": "Kyoko",
                    "initial": "K.",
                    "last": "Shinya"
                },
                {
                    "first": "Gongxun",
                    "initial": "G.",
                    "last": "Zhong"
                },
                {
                    "first": "Anthony",
                    "initial": "A.",
                    "last": "Hanson"
                },
                {
                    "first": "Hiroaki",
                    "initial": "H.",
                    "last": "Katsura"
                },
                {
                    "first": "Shinji",
                    "initial": "S.",
                    "last": "Watanabe"
                },
                {
                    "first": "Chengjun",
                    "initial": "C.",
                    "last": "Li"
                },
                {
                    "first": "Eiryo",
                    "initial": "E.",
                    "last": "Kawakami"
                },
                {
                    "first": "Shinya",
                    "initial": "S.",
                    "last": "Yamada"
                },
                {
                    "first": "Maki",
                    "initial": "M.",
                    "last": "Kiso"
                },
                {
                    "first": "Yasuo",
                    "initial": "Y.",
                    "last": "Suzuki"
                },
                {
                    "first": "Eileen A.",
                    "initial": "E.A.",
                    "last": "Maher"
                },
                {
                    "first": "Gabriele",
                    "initial": "G.",
                    "last": "Neumann"
                },
                {
                    "first": "Yoshihiro",
                    "initial": "Y.",
                    "last": "Kawaoka"
                }
            ],
            "doi": "10.1038/nature10831",
            "firstpage": "420",
            "issn": "00280836",
            "lastpage": "428",
            "pmid": "22722205",
            "pub_year": 2012,
            "title": "Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets",
            "volume": "486"
        },
        "b0195": null,
        "b0200": {
            "authors": [
                {
                    "first": "Chavela M.",
                    "initial": "C.M.",
                    "last": "Carr"
                },
                {
                    "first": "Peter S.",
                    "initial": "P.S.",
                    "last": "Kim"
                }
            ],
            "doi": "10.1016/0092-8674(93)90260-W",
            "firstpage": "823",
            "issn": "00928674",
            "lastpage": "832",
            "pmid": "8500173",
            "pub_year": 1993,
            "title": "A spring-loaded mechanism for the conformational change of influenza hemagglutinin",
            "volume": "73"
        },
        "b0205": {
            "authors": [
                {
                    "first": "A. S.",
                    "initial": "A.S.",
                    "last": "Gambaryan"
                },
                {
                    "first": "V. P.",
                    "initial": "V.P.",
                    "last": "Marinina"
                },
                {
                    "first": "A. B.",
                    "initial": "A.B.",
                    "last": "Tuzikov"
                },
                {
                    "first": "N. V.",
                    "initial": "N.V.",
                    "last": "Bovin"
                },
                {
                    "first": "I. A.",
                    "initial": "I.A.",
                    "last": "Rudneva"
                },
                {
                    "first": "B. V.",
                    "initial": "B.V.",
                    "last": "Sinitsyn"
                },
                {
                    "first": "A. A.",
                    "initial": "A.A.",
                    "last": "Shilov"
                },
                {
                    "first": "M. N.",
                    "initial": "M.N.",
                    "last": "Matrosovich"
                }
            ],
            "doi": "10.1006/viro.1998.9224",
            "firstpage": "170",
            "issn": "00426822",
            "lastpage": "177",
            "pmid": "9705910",
            "pub_year": 1998,
            "title": "Effects of host-dependent glycosylation of hemagglutinin on receptor- binding properties of H1N1 human influenza A virus grown in MDCK cells and in embryonated eggs",
            "volume": "247"
        },
        "b0210": null,
        "b0215": {
            "authors": [
                {
                    "first": "Tracie L.",
                    "initial": "T.L.",
                    "last": "Williams"
                },
                {
                    "first": "James L.",
                    "initial": "J.L.",
                    "last": "Pirkle"
                },
                {
                    "first": "John R.",
                    "initial": "J.R.",
                    "last": "Barr"
                }
            ],
            "doi": "10.1016/j.vaccine.2011.12.056",
            "firstpage": "2475",
            "issn": "0264410X",
            "lastpage": "2482",
            "pmid": "22197963",
            "pub_year": 2012,
            "title": "Simultaneous quantification of hemagglutinin and neuraminidase of influenza virus using isotope dilution mass spectrometry",
            "volume": "30"
        },
        "b0220": {
            "authors": [
                {
                    "first": "Hang Sik",
                    "initial": "H.S.",
                    "last": "Roh"
                },
                {
                    "first": "Hye Min",
                    "initial": "H.M.",
                    "last": "Song"
                },
                {
                    "first": "Bo Reum",
                    "initial": "B.R.",
                    "last": "Yun"
                },
                {
                    "first": "Hyun Kyung",
                    "initial": "H.K.",
                    "last": "Kang"
                },
                {
                    "first": "Keum Suk",
                    "initial": "K.S.",
                    "last": "Choi"
                },
                {
                    "first": "Yun Ju",
                    "initial": "Y.J.",
                    "last": "Park"
                },
                {
                    "first": "Dong Sub",
                    "initial": "D.S.",
                    "last": "Kim"
                },
                {
                    "first": "Seung Hee",
                    "initial": "S.H.",
                    "last": "Kim"
                },
                {
                    "first": "In Pil",
                    "initial": "I.P.",
                    "last": "Mo"
                },
                {
                    "first": "Beum Soo",
                    "initial": "B.S.",
                    "last": "An"
                },
                {
                    "first": "Chi Young",
                    "initial": "C.Y.",
                    "last": "Ahn"
                }
            ],
            "doi": "10.3892/mmr.2014.3049",
            "firstpage": "2819",
            "issn": "17912997",
            "lastpage": "2824",
            "pmid": "25482872",
            "pub_year": 2015,
            "title": "A hemagglutinin quantification method for development of an influenza pandemic vaccine using size exclusion high performance liquid chromatography",
            "volume": "11"
        },
        "b0225": {
            "authors": [
                {
                    "first": "Changgui",
                    "initial": "C.",
                    "last": "Li"
                },
                {
                    "first": "Bozena",
                    "initial": "B.",
                    "last": "Jaentschke"
                },
                {
                    "first": "Yingli",
                    "initial": "Y.",
                    "last": "Song"
                },
                {
                    "first": "Junzhi",
                    "initial": "J.",
                    "last": "Wang"
                },
                {
                    "first": "Terry D.",
                    "initial": "T.D.",
                    "last": "Cyr"
                },
                {
                    "first": "Gary",
                    "initial": "G.",
                    "last": "Van Domselaar"
                },
                {
                    "first": "Runtao",
                    "initial": "R.",
                    "last": "He"
                },
                {
                    "first": "Xuguang",
                    "initial": "X.",
                    "last": "Li"
                }
            ],
            "doi": "10.1038/nprot.2009.200",
            "firstpage": "14",
            "issn": "17542189",
            "lastpage": "19",
            "pmid": "20010723",
            "pub_year": 2010,
            "title": "A simple slot blot for the detection of virtually all subtypes of the influenza A viral hemagglutinins using universal antibodies targeting the fusion peptide",
            "volume": "5"
        },
        "b0230": {
            "authors": [
                {
                    "first": "Manon M.J.",
                    "initial": "M.M.J.",
                    "last": "Cox"
                },
                {
                    "first": "Jason R.",
                    "initial": "J.R.",
                    "last": "Hollister"
                }
            ],
            "doi": "10.1016/j.biologicals.2009.02.014",
            "firstpage": "182",
            "issn": "10451056",
            "lastpage": "189",
            "pmid": "19297194",
            "pub_year": 2009,
            "title": "FluBlok, a next generation influenza vaccine manufactured in insect cells",
            "volume": "37"
        },
        "b0235": {
            "authors": [
                {
                    "first": "Jerry P.",
                    "initial": "J.P.",
                    "last": "Weir"
                },
                {
                    "first": "Marion F.",
                    "initial": "M.F.",
                    "last": "Gruber"
                }
            ],
            "doi": "10.1111/irv.12383",
            "firstpage": "354",
            "issn": "17502640",
            "lastpage": "360",
            "pmid": "27426005",
            "pub_year": 2016,
            "title": "An overview of the regulation of influenza vaccines in the United States",
            "volume": "10"
        },
        "b0240": {
            "authors": [
                {
                    "first": "Hadi M.",
                    "initial": "H.M.",
                    "last": "Yassine"
                },
                {
                    "first": "Jeffrey C.",
                    "initial": "J.C.",
                    "last": "Boyington"
                },
                {
                    "first": "Patrick M.",
                    "initial": "P.M.",
                    "last": "McTamney"
                },
                {
                    "first": "Chih Jen",
                    "initial": "C.J.",
                    "last": "Wei"
                },
                {
                    "first": "Masaru",
                    "initial": "M.",
                    "last": "Kanekiyo"
                },
                {
                    "first": "Wing Pui",
                    "initial": "W.P.",
                    "last": "Kong"
                },
                {
                    "first": "John R.",
                    "initial": "J.R.",
                    "last": "Gallagher"
                },
                {
                    "first": "Lingshu",
                    "initial": "L.",
                    "last": "Wang"
                },
                {
                    "first": "Yi",
                    "initial": "Y.",
                    "last": "Zhang"
                },
                {
                    "first": "M. Gordon",
                    "initial": "M.G.",
                    "last": "Joyce"
                },
                {
                    "first": "Daniel",
                    "initial": "D.",
                    "last": "Lingwood"
                },
                {
                    "first": "Syed M.",
                    "initial": "S.M.",
                    "last": "Moin"
                },
                {
                    "first": "Hanne",
                    "initial": "H.",
                    "last": "Andersen"
                },
                {
                    "first": "Yoshinobu",
                    "initial": "Y.",
                    "last": "Okuno"
                },
                {
                    "first": "Srinivas S.",
                    "initial": "S.S.",
                    "last": "Rao"
                },
                {
                    "first": "Audray K.",
                    "initial": "A.K.",
                    "last": "Harris"
                },
                {
                    "first": "Peter D.",
                    "initial": "P.D.",
                    "last": "Kwong"
                },
                {
                    "first": "John R.",
                    "initial": "J.R.",
                    "last": "Mascola"
                },
                {
                    "first": "Gary J.",
                    "initial": "G.J.",
                    "last": "Nabel"
                },
                {
                    "first": "Barney S.",
                    "initial": "B.S.",
                    "last": "Graham"
                }
            ],
            "doi": "10.1038/nm.3927",
            "firstpage": "1065",
            "issn": "10788956",
            "lastpage": "1070",
            "pmid": "26301691",
            "pub_year": 2015,
            "title": "Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection",
            "volume": "21"
        },
        "b0245": {
            "authors": [
                {
                    "first": "Antonietta",
                    "initial": "A.",
                    "last": "Impagliazzo"
                },
                {
                    "first": "Fin",
                    "initial": "F.",
                    "last": "Milder"
                },
                {
                    "first": "Harmjan",
                    "initial": "H.",
                    "last": "Kuipers"
                },
                {
                    "first": "Michelle V.",
                    "initial": "M.V.",
                    "last": "Wagner"
                },
                {
                    "first": "Xueyong",
                    "initial": "X.",
                    "last": "Zhu"
                },
                {
                    "first": "Ryan M.B.",
                    "initial": "R.M.B.",
                    "last": "Hoffman"
                },
                {
                    "first": "Ruud",
                    "initial": "R.",
                    "last": "Van Meersbergen"
                },
                {
                    "first": "Jeroen",
                    "initial": "J.",
                    "last": "Huizingh"
                },
                {
                    "first": "Patrick",
                    "initial": "P.",
                    "last": "Wanningen"
                },
                {
                    "first": "Johan",
                    "initial": "J.",
                    "last": "Verspuij"
                },
                {
                    "first": "Martijn",
                    "initial": "M.",
                    "last": "De Man"
                },
                {
                    "first": "Zhaoqing",
                    "initial": "Z.",
                    "last": "Ding"
                },
                {
                    "first": "Adrian",
                    "initial": "A.",
                    "last": "Apetri"
                },
                {
                    "first": "Basak",
                    "initial": "B.",
                    "last": "K\u00fckrer"
                },
                {
                    "first": "Eveline",
                    "initial": "E.",
                    "last": "Sneekes-Vriese"
                },
                {
                    "first": "Danuta",
                    "initial": "D.",
                    "last": "Tomkiewicz"
                },
                {
                    "first": "Nick S.",
                    "initial": "N.S.",
                    "last": "Laursen"
                },
                {
                    "first": "Peter S.",
                    "initial": "P.S.",
                    "last": "Lee"
                },
                {
                    "first": "Anna",
                    "initial": "A.",
                    "last": "Zakrzewska"
                },
                {
                    "first": "Liesbeth",
                    "initial": "L.",
                    "last": "Dekking"
                },
                {
                    "first": "Jeroen",
                    "initial": "J.",
                    "last": "Tolboom"
                },
                {
                    "first": "Lisanne",
                    "initial": "L.",
                    "last": "Tettero"
                },
                {
                    "first": "Sander",
                    "initial": "S.",
                    "last": "Van Meerten"
                },
                {
                    "first": "Wenli",
                    "initial": "W.",
                    "last": "Yu"
                },
                {
                    "first": "Wouter",
                    "initial": "W.",
                    "last": "Koudstaal"
                },
                {
                    "first": "Jaap",
                    "initial": "J.",
                    "last": "Goudsmit"
                },
                {
                    "first": "Andrew B.",
                    "initial": "A.B.",
                    "last": "Ward"
                },
                {
                    "first": "Wim",
                    "initial": "W.",
                    "last": "Meijberg"
                },
                {
                    "first": "Ian A.",
                    "initial": "I.A.",
                    "last": "Wilson"
                },
                {
                    "first": "Katarina",
                    "initial": "K.",
                    "last": "Rado\u0161evic"
                }
            ],
            "doi": "10.1126/science.aac7263",
            "firstpage": "1301",
            "issn": "00368075",
            "lastpage": "1306",
            "pmid": "26303961",
            "pub_year": 2015,
            "title": "A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen",
            "volume": "349"
        },
        "b0250": {
            "authors": [
                {
                    "first": "Teddy John",
                    "initial": "T.J.",
                    "last": "Wohlbold"
                },
                {
                    "first": "Raffael",
                    "initial": "R.",
                    "last": "Nachbagauer"
                },
                {
                    "first": "Irina",
                    "initial": "I.",
                    "last": "Margine"
                },
                {
                    "first": "Gene S.",
                    "initial": "G.S.",
                    "last": "Tan"
                },
                {
                    "first": "Ariana",
                    "initial": "A.",
                    "last": "Hirsh"
                },
                {
                    "first": "Florian",
                    "initial": "F.",
                    "last": "Krammer"
                }
            ],
            "doi": "10.1016/j.vaccine.2015.05.038",
            "firstpage": "3314",
            "issn": "0264410X",
            "lastpage": "3321",
            "pmid": "26026378",
            "pub_year": 2015,
            "title": "Vaccination with soluble headless hemagglutinin protects mice from challenge with divergent influenza viruses",
            "volume": "33"
        }
    },
    "body_text": [
        {
            "endOffset": 37490,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "The exposure of the stalk region is expected to enhance antibody binding, and therefore, antigens were pretreated under various conditions to enhance ELISA responses.",
            "startOffset": 37324,
            "title": "Pretreatment of HA antigens"
        },
        {
            "endOffset": 52287,
            "parents": [],
            "refoffsets": {
                "b0230": {
                    "endOffset": 52162,
                    "startOffset": 52158
                },
                "b0235": {
                    "endOffset": 52286,
                    "startOffset": 52282
                }
            },
            "secId": "s0105",
            "sentence": "Of note, recombinant subunit vaccine derived from insect cells has been licensed [46], and the current SRID method, optimized for egg-based influenza vaccines, may not be suitable for recombinant vaccines [47].",
            "startOffset": 52077,
            "title": "Discussion"
        },
        {
            "endOffset": 29369,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0020",
            "sentence": "The supernatants in purification buffer (50 mM Tris-cl (pH 7.5), 300 mM NaCl, 10 mM imidazole, 10% glycerol, 2 mM mercaptoethanol, 0.1% Tween-20) were loaded into a Ni-nitrilotriacetic acid resin column and were eluted with a linear gradient of imidazole (10\u2013300 mM).",
            "startOffset": 29102,
            "title": "Cloning, expression, and purification of the cHA stalk"
        },
        {
            "endOffset": 33828,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0055",
            "sentence": "Results are reported as the mean \u00b1 standard deviation.",
            "startOffset": 33774,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 49899,
            "parents": [],
            "secId": "s0105",
            "sentence": "Yet, we observed differences in the magnitudes of ELISA responses of the mAbs against various subtypes of HA within the same group (Figs. 6 and Supplemental Fig. S4\u2013S7).",
            "startOffset": 49730,
            "title": "Discussion"
        },
        {
            "endOffset": 51742,
            "parents": [],
            "secId": "s0105",
            "sentence": "Furthermore, the quantitative ELISA we developed shows improved sensitivity and repeatability (Tables 1, Supplemental Table 4 and 5).",
            "startOffset": 51609,
            "title": "Discussion"
        },
        {
            "endOffset": 34408,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "The H1 fragment was used as a template considering its abundance among various subtypes.",
            "startOffset": 34320,
            "title": "Generation and analysis of cHA stalk"
        },
        {
            "endOffset": 36797,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0075",
            "sentence": "Two positive mAbs, 1G5 and 2C12, were selected and their binding specificity was screened by ELISA (Fig. 3).",
            "startOffset": 36689,
            "title": "mAb generation and validation"
        },
        {
            "endOffset": 25472,
            "parents": [],
            "secId": "s0005",
            "sentence": "In the current study, we developed a new HA quantitative enzyme-linked immunosorbent assay (ELISA) using a universal monoclonal antibody (mAb) that can bind to HA antigens from various subtypes and drift strains.",
            "startOffset": 25260,
            "title": "Introduction"
        },
        {
            "endOffset": 34728,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "In-silico predictions verified that an expected secondary structure of the cHA stalk was compatible with those of naturally occurring HA of group 1 IAVs (Fig. 1C).",
            "startOffset": 34565,
            "title": "Generation and analysis of cHA stalk"
        },
        {
            "endOffset": 45882,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0100",
            "sentence": "The SRID assay was conducted as described in Section 2.7.",
            "startOffset": 45825,
            "title": "Comparison between SRID and ELISA"
        },
        {
            "endOffset": 36922,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0075",
            "sentence": "Thus, we can conclude that the two mAbs are cHA stalk specific.",
            "startOffset": 36859,
            "title": "mAb generation and validation"
        },
        {
            "endOffset": 39085,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0125": {
                    "endOffset": 39008,
                    "startOffset": 39004
                }
            },
            "secId": "s0080",
            "sentence": "Urea is generally used to disrupt protein structure [25], and different concentrations of urea in PBS buffer were tested (Fig. 4I\u2013L).",
            "startOffset": 38952,
            "title": "Pretreatment of HA antigens"
        },
        {
            "endOffset": 40846,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0085",
            "sentence": "In terms of linearity, both antibodies showed high coefficient of determination (R2) values: for 1G5, R2 was 0.9955 \u00b1 0.0035 and for 2C12, R2 was 0.9949 \u00b1 0.0059.",
            "startOffset": 40684,
            "title": "ELISA with recombinant HA antigens"
        },
        {
            "endOffset": 48043,
            "parents": [],
            "secId": "s0105",
            "sentence": "However, the assay could not differentiate between groups 1 and 2, and thus was unable to quantify each HA component in multivalent vaccine formulations.",
            "startOffset": 47890,
            "title": "Discussion"
        },
        {
            "endOffset": 53674,
            "parents": [],
            "secId": "s0105",
            "sentence": "To render it amenable to high-throughput testing, validation of the method as an alternative for the current SRID assay is needed.",
            "startOffset": 53544,
            "title": "Discussion"
        },
        {
            "endOffset": 33454,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0050",
            "sentence": "The standard and test antigens were treated with 10% (w/v) Zwittergent 3-14 detergent (Sigma-Aldrich, St. Louis, MO) solution at a 9:1 ratio at room temperature for 30 min.",
            "startOffset": 33282,
            "title": "Quantification of HA antigens by ELISA"
        },
        {
            "endOffset": 33621,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0050",
            "sentence": "Next, both antigens were pretreated under the condition of pH 5.0 and 100 mM DTT at room temperature for 30 min and coated in duplicate on 96-well immunoassay plates.",
            "startOffset": 33455,
            "title": "Quantification of HA antigens by ELISA"
        },
        {
            "endOffset": 30367,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Two selected clones, 1G5 and 2C12, were purified using Protein G resin (GE Healthcare, Chicago, IL) and dialyzed against PBS.",
            "startOffset": 30242,
            "title": "Generation of monoclonal antibody"
        },
        {
            "endOffset": 35404,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0045": {
                    "endOffset": 35403,
                    "startOffset": 35400
                }
            },
            "secId": "s0070",
            "sentence": "The cHA stalk was genetically fused with an RNA-interacting domain of lysyl-tRNA synthetase from mouse (mRID) for soluble expression (Fig. 2A) [9].",
            "startOffset": 35257,
            "title": "Expression and purification of mRID-cHA stalk"
        },
        {
            "endOffset": 39606,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "In conclusion, the optimal HA antigen pretreatment was established as pre-binding treatment under the condition of pH 5.0 and 100 mM DTT.",
            "startOffset": 39469,
            "title": "Pretreatment of HA antigens"
        },
        {
            "endOffset": 43345,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0090",
            "sentence": "In addition, data of ELISAs with group 1 IAV HA were subjected to linear regression to estimate their statistical significance (Table 1).",
            "startOffset": 43208,
            "title": "ELISA with standard HA antigens"
        },
        {
            "endOffset": 39168,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "ELISA responses increased up to 5 M urea and were higher in pre-binding condition.",
            "startOffset": 39086,
            "title": "Pretreatment of HA antigens"
        },
        {
            "endOffset": 26306,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "HA sequences from human isolates were collected from the Influenza Virus Resource at the National Center for Biotechnology Information.",
            "startOffset": 26171,
            "title": "Sequence analysis for cHA stalk"
        },
        {
            "endOffset": 47889,
            "parents": [],
            "refoffsets": {
                "b0145": {
                    "endOffset": 47888,
                    "startOffset": 47884
                }
            },
            "secId": "s0105",
            "sentence": "One study used a mAb targeting the fusion peptide of HA that universally bound to various HAs [29].",
            "startOffset": 47790,
            "title": "Discussion"
        },
        {
            "endOffset": 52759,
            "parents": [],
            "secId": "s0105",
            "sentence": "Moreover, the ELISA is suitable for a universal vaccine that would provide cross-protection against multiple influenza viruses of either seasonal or pandemic nature.",
            "startOffset": 52594,
            "title": "Discussion"
        },
        {
            "endOffset": 31312,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0035",
            "sentence": "Under the pre-binding condition, the antigen solution and the buffer were mixed at a 1:1 ratio and incubated at room temperature for 30 min before binding to the plate.",
            "startOffset": 31144,
            "title": "Antigen pretreatment"
        },
        {
            "endOffset": 48676,
            "parents": [],
            "refoffsets": {
                "b0155": {
                    "endOffset": 48602,
                    "startOffset": 48598
                },
                "b0160": {
                    "endOffset": 48675,
                    "startOffset": 48671
                }
            },
            "secId": "s0105",
            "sentence": "H2 subtype strains were responsible for the pandemic outbreak in 1957 [31], and had circulated for a decade before replacement by H3N2 in 1968 [32].",
            "startOffset": 48528,
            "title": "Discussion"
        },
        {
            "endOffset": 33157,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0050",
            "sentence": "The standard HA antigen used was from A/Singapore/GP1908/2015 (IVR-180) (NIBSC product number: 16/292).",
            "startOffset": 33054,
            "title": "Quantification of HA antigens by ELISA"
        },
        {
            "endOffset": 38624,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "ELISA responses were increased with increasing concentration of DTT; the responses in 100 mM DTT were approximately 1.5 times higher than those in the absence of DTT, regardless of pre- or post-binding treatment.",
            "startOffset": 38412,
            "title": "Pretreatment of HA antigens"
        },
        {
            "endOffset": 28472,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0020",
            "sentence": "A cHA stalk gene that was codon-optimized to E. coli was synthesized (BIONICS, Seoul, Korea), PCR-amplified, and inserted into the expression vector.",
            "startOffset": 28323,
            "title": "Cloning, expression, and purification of the cHA stalk"
        },
        {
            "endOffset": 37174,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0105": {
                    "endOffset": 37173,
                    "startOffset": 37169
                }
            },
            "secId": "s0080",
            "sentence": "HA is composed of a HA1 globular domain and a HA2 stalk domain, which are linked by disulfide bonds [21].",
            "startOffset": 37069,
            "title": "Pretreatment of HA antigens"
        },
        {
            "endOffset": 35991,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "Here, mRID (\u201cself\u201d) was judiciously chosen because it is expected to be non-immunogenic in mice, and therefore, antibodies would be elicited predominantly to the \u201cforeign\u201d cHA domain, greatly facilitating the screening of clones of desired specificity.",
            "startOffset": 35739,
            "title": "Expression and purification of mRID-cHA stalk"
        },
        {
            "endOffset": 24375,
            "parents": [],
            "refoffsets": {
                "b0025": {
                    "endOffset": 24374,
                    "startOffset": 24371
                }
            },
            "secId": "s0005",
            "sentence": "Since the 1970s, single radial immunodiffusion (SRID) assay has been standardly used for HA quantitation to validate vaccine potency [5].",
            "startOffset": 24238,
            "title": "Introduction"
        },
        {
            "endOffset": 27550,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "The accessibility and polarity of the computationally designed cHA stalk were calculated and compared with those from naturally occurring infectious viruses.",
            "startOffset": 27393,
            "title": "Sequence analysis for cHA stalk"
        },
        {
            "endOffset": 37653,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "Most notably, ELISA responses were highly increased when the buffer pH was lower than 5.0.",
            "startOffset": 37563,
            "title": "Pretreatment of HA antigens"
        },
        {
            "endOffset": 42367,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0090",
            "sentence": "All the standard antigens were egg-derived and supplied by the NIBSC.",
            "startOffset": 42298,
            "title": "ELISA with standard HA antigens"
        },
        {
            "endOffset": 43826,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0090",
            "sentence": "However, slight differences were observed among HA antigens from different strains.",
            "startOffset": 43743,
            "title": "ELISA with standard HA antigens"
        },
        {
            "endOffset": 32549,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0040",
            "sentence": "The optical density at 450 nm was measured using a FLUOstar Optima microplate reader (BMG Labtech, Ortenberg, Germany).",
            "startOffset": 32430,
            "title": "Indirect ELISA"
        },
        {
            "endOffset": 33670,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0050",
            "sentence": "ELISA was conducted as described in Section 2.6.",
            "startOffset": 33622,
            "title": "Quantification of HA antigens by ELISA"
        },
        {
            "endOffset": 38085,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "Moreover, the ELISA responses depended on the time point of pretreatment; pre-binding treatment resulted in significantly higher responses than post-binding treatment, although pH dependence remained sustained.",
            "startOffset": 37875,
            "title": "Pretreatment of HA antigens"
        },
        {
            "endOffset": 31785,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0040",
            "sentence": "HA antigens were coated on 96-well immunoassay plates (Nunc-Immuno\u2122 MicroWell\u2122 96 well solid plates; Thermo Fisher, Waltham, MA) and incubated at 4 \u00b0C overnight.",
            "startOffset": 31624,
            "title": "Indirect ELISA"
        },
        {
            "endOffset": 25737,
            "parents": [],
            "refoffsets": {
                "b0040": {
                    "endOffset": 25736,
                    "startOffset": 25731
                },
                "b0045": {
                    "endOffset": 25736,
                    "startOffset": 25731
                }
            },
            "secId": "s0005",
            "sentence": "The antigens were expressed in Escherichia coli based on an RNA-mediated chaperone expression system and purified as a soluble form [8,9].",
            "startOffset": 25599,
            "title": "Introduction"
        },
        {
            "endOffset": 27734,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0060": {
                    "endOffset": 27662,
                    "startOffset": 27658
                }
            },
            "secId": "s0015",
            "sentence": "For the calculation, a monomer structure of the cHA stalk was built by homology modeling using SWISS-MODEL [12] based on the HA structure of A/Brevig Mission/1918 H1N1 (PDB ID: 1RUZ).",
            "startOffset": 27551,
            "title": "Sequence analysis for cHA stalk"
        },
        {
            "endOffset": 34564,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "Then, the secondary structure of the cHA stalk was predicted to confirm whether the deduced cHA stalk structure was compatible with the viral HA structure.",
            "startOffset": 34409,
            "title": "Generation and analysis of cHA stalk"
        },
        {
            "endOffset": 26888,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Finally, a consensus HA (cHA) stalk sequence for group 1 was generated by merging all high frequency fragments of subtypes H1, H2, H5, and H9, using the H1 fragment as a template.",
            "startOffset": 26709,
            "title": "Sequence analysis for cHA stalk"
        },
        {
            "endOffset": 32139,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0040",
            "sentence": "Then, the diluted murine mAb was added and incubated at 37 \u00b0C for 2 h. Subsequently, horseradish peroxidase-conjugated goat anti-mouse IgG antibody (Sigma-Aldrich, St. Louis, MO) was added and incubated at 37 \u00b0C for 1 h.",
            "startOffset": 31919,
            "title": "Indirect ELISA"
        },
        {
            "endOffset": 45201,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0095",
            "sentence": "However, both antibodies failed to bind to HA of A/Hong Kong/4801/2014 (NYMC X-263B) (H3N2), B/Phuket/3073/2013 (Yamagata-like), and B/Brisbane/60/2008 (Victoria-like).",
            "startOffset": 45033,
            "title": "ELISA with quadrivalent vaccine HA antigens"
        },
        {
            "endOffset": 49729,
            "parents": [],
            "secId": "s0105",
            "sentence": "Our approach was therefore to use the stalk domain, and to enhance cross-reactivity further, a consensus sequence deduced from multiple HA subtypes within group 1 IAVs was employed as immunogen (Fig. 1B).",
            "startOffset": 49525,
            "title": "Discussion"
        },
        {
            "endOffset": 31143,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0035",
            "sentence": "HA antigens were mixed with various pretreatment buffers with different pH, 1,4-dithiothreitol (DTT; Gold Biotechnology, St. Louis, MO) concentrations, and urea (Sigma-Aldrich, St. Louis, MO) concentrations either prior to (pre-binding) or after binding to (post-binding) the ELISA plate.",
            "startOffset": 30855,
            "title": "Antigen pretreatment"
        },
        {
            "endOffset": 38285,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0115": {
                    "endOffset": 38156,
                    "startOffset": 38152
                },
                "b0120": {
                    "endOffset": 38256,
                    "startOffset": 38252
                }
            },
            "secId": "s0080",
            "sentence": "Considering that HA1 and HA2 domains are linked by disulfide bonds [23], treatment of HA with a reducing agent, e.g., DTT, is expected to release the HA1 from the HA2 [24] and expose the stalk region.",
            "startOffset": 38085,
            "title": "Pretreatment of HA antigens"
        },
        {
            "endOffset": 25816,
            "parents": [],
            "secId": "s0005",
            "sentence": "Then, mAbs were generated and screened for specific binding to group 1 IAV HA.",
            "startOffset": 25738,
            "title": "Introduction"
        },
        {
            "endOffset": 44979,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0095",
            "sentence": "For 1G5, R2 was 0.9991, and for 2C12, R2 was 0.9949.",
            "startOffset": 44927,
            "title": "ELISA with quadrivalent vaccine HA antigens"
        },
        {
            "endOffset": 26115,
            "parents": [],
            "secId": "s0005",
            "sentence": "Calibration curves for various subtypes of HA antigens\u2014recombinant HA, NIBSC standard HA reagents, and quadrivalent influenza vaccine HA antigens\u2014were generated for optimization of ELISA-based quantitation of HA antigens with respect to accuracy, specificity, sensitivity, and linear dynamic range.",
            "startOffset": 25817,
            "title": "Introduction"
        },
        {
            "endOffset": 30751,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0030",
            "sentence": "HA antigens of various origin were used; recombinant HA produced from HEK293 cells or insect cells (Sino Biological, Beijing, China), the standard HA antigens from the National Institute for Biological Standards and Control (NIBSC, Blanche Lane, UK) and quadrivalent seasonal influenza vaccine (GC flu) produced by Green Cross Pharma (Yongin, Korea).",
            "startOffset": 30401,
            "title": "Reference HA antigens for ELISA"
        },
        {
            "endOffset": 32205,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0040",
            "sentence": "At each step, the wells were washed with PBS with 0.05% Tween-20.",
            "startOffset": 32140,
            "title": "Indirect ELISA"
        },
        {
            "endOffset": 32634,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0025": {
                    "endOffset": 32607,
                    "startOffset": 32604
                }
            },
            "secId": "s0045",
            "sentence": "The SRID assay was conducted as described [5], with minor modifications.",
            "startOffset": 32562,
            "title": "SRID assay"
        },
        {
            "endOffset": 48424,
            "parents": [],
            "secId": "s0105",
            "sentence": "The group-specificity of the mAbs used in this study was tested among various subtypes, including H1, H2, H5, and H9.",
            "startOffset": 48307,
            "title": "Discussion"
        },
        {
            "endOffset": 49940,
            "parents": [],
            "secId": "s0105",
            "sentence": "There are several possible explanations.",
            "startOffset": 49900,
            "title": "Discussion"
        },
        {
            "endOffset": 46896,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0100",
            "sentence": "However, the ELISA can produce more accurate and reliable result than SRID method.",
            "startOffset": 46814,
            "title": "Comparison between SRID and ELISA"
        },
        {
            "endOffset": 31435,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0035",
            "sentence": "Under the post-binding condition, the HA antigen was bound to the plate and incubated with pretreatment buffer for 30 min.",
            "startOffset": 31313,
            "title": "Antigen pretreatment"
        },
        {
            "endOffset": 33970,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0055",
            "sentence": "Four-parameter linear regression was conducted to analyze ELISA results, using GraphPad Prism version 5.01 (GraphPad Software, La Jolla, CA).",
            "startOffset": 33829,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 45494,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0095",
            "sentence": "The group 1 specificity of the mAbs, as proven for recombinant HAs (Supplemental Figs. S4 and S5), egg-derived standards (Supplemental Figs. S6 and S7), and commercial vaccines (Fig. 6), strongly suggests their utility in an ELISA-based assay for the quantitation of HA in influenza vaccines.",
            "startOffset": 45202,
            "title": "ELISA with quadrivalent vaccine HA antigens"
        },
        {
            "endOffset": 51322,
            "parents": [],
            "refoffsets": {
                "b0130": {
                    "endOffset": 51242,
                    "startOffset": 51229
                },
                "b0135": {
                    "endOffset": 51242,
                    "startOffset": 51229
                },
                "b0145": {
                    "endOffset": 51242,
                    "startOffset": 51229
                },
                "b0215": {
                    "endOffset": 51156,
                    "startOffset": 51152
                },
                "b0220": {
                    "endOffset": 51201,
                    "startOffset": 51197
                },
                "b0225": {
                    "endOffset": 51242,
                    "startOffset": 51229
                }
            },
            "secId": "s0105",
            "sentence": "Other methods have been developed independently, including mass spectrometry [43], high-performance liquid chromatography [44], and antibody-based assays [26,27,29,45], and should be compared for robustness of quantification and user friendliness.",
            "startOffset": 51075,
            "title": "Discussion"
        },
        {
            "endOffset": 26412,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "The library contains sequences from H1 (11,205), H2 (159), H5 (433), and H9 (12), which are group 1 IAVs.",
            "startOffset": 26307,
            "title": "Sequence analysis for cHA stalk"
        },
        {
            "endOffset": 29101,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0020",
            "sentence": "An \u00c4KTA prime plus chromatography system (GE Healthcare, Chicago, IL) and a HisTrap HP column (GE Healthcare, Chicago, IL) were used for purification.",
            "startOffset": 28951,
            "title": "Cloning, expression, and purification of the cHA stalk"
        },
        {
            "endOffset": 47153,
            "parents": [],
            "secId": "s0105",
            "sentence": "The current standard method for HA quantification, the SRID assay, represents a hurdle for timely vaccine licensing because of its intrinsic limitations.",
            "startOffset": 47000,
            "title": "Discussion"
        },
        {
            "endOffset": 51471,
            "parents": [],
            "secId": "s0105",
            "sentence": "As an alternative method, the present ELISA is easy to perform, is substantially less time-consuming than SRID (hours vs. days) and can be automated.",
            "startOffset": 51322,
            "title": "Discussion"
        },
        {
            "endOffset": 40505,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0085",
            "sentence": "Thus, 1G5 and 2C12 were confirmed to be specific to group 1 IAV recombinant HAs derived from eukaryotes.",
            "startOffset": 40401,
            "title": "ELISA with recombinant HA antigens"
        },
        {
            "endOffset": 44283,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0090",
            "sentence": "Thus, 1G5 and 2C12 are group 1 IAV HA-specific, without cross-reactivity to HAs belonging to group 2 IAV or IBV, showing high degrees of linearity, sensitivity, and reproducibility.",
            "startOffset": 44102,
            "title": "ELISA with standard HA antigens"
        },
        {
            "endOffset": 46516,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0100",
            "sentence": "The concentrations determined by SRID and ELISA were similar, but those from ELISA were slightly higher than those from SRID.",
            "startOffset": 46391,
            "title": "Comparison between SRID and ELISA"
        },
        {
            "endOffset": 36611,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "The protein was concentrated through a centrifugal filter (10 kDa) (1.4 mg/ml) and used for immunization of mice to generate mAbs.",
            "startOffset": 36481,
            "title": "Expression and purification of mRID-cHA stalk"
        },
        {
            "endOffset": 26708,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Then, high frequency fragments that were consisted with highly conserved amino acid residues of each HA subtype were obtained.",
            "startOffset": 26582,
            "title": "Sequence analysis for cHA stalk"
        },
        {
            "endOffset": 27393,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Then, the predicted structure of cHA stalk was compared with the structures of the above-mentioned wild-type viral HAs.",
            "startOffset": 27274,
            "title": "Sequence analysis for cHA stalk"
        },
        {
            "endOffset": 41861,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0085",
            "sentence": "Detailed CV values for all ELISAs are presented in Table S4, and indicate that the results of repeated ELISAs were reliable.",
            "startOffset": 41737,
            "title": "ELISA with recombinant HA antigens"
        },
        {
            "endOffset": 45032,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0095",
            "sentence": "The CV values were \u223c4.1%, and LODs were <0.02 \u00b5g/ml.",
            "startOffset": 44980,
            "title": "ELISA with quadrivalent vaccine HA antigens"
        },
        {
            "endOffset": 53103,
            "parents": [],
            "secId": "s0105",
            "sentence": "Traditional SRID based on polyclonal anti-serum with strain-specific immune responses targeting to the immunologically dominant HA globular domain is unable to validate these vaccines.",
            "startOffset": 52919,
            "title": "Discussion"
        },
        {
            "endOffset": 51608,
            "parents": [],
            "secId": "s0105",
            "sentence": "Being less subject to the experience and skill of the experimenter, the results are more reproducible, resulting in a lower error range.",
            "startOffset": 51472,
            "title": "Discussion"
        },
        {
            "endOffset": 35209,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "In summary, the cHA stalk was structurally and immunologically compatible with viral HA, and suitable for the generation of universal mAbs.",
            "startOffset": 35070,
            "title": "Generation and analysis of cHA stalk"
        },
        {
            "endOffset": 47583,
            "parents": [],
            "secId": "s0105",
            "sentence": "The present approach could be extended to HAs of group 2 IAVs as well as to IBVs for the quantitation of HA antigens of multivalent seasonal influenza vaccines.",
            "startOffset": 47423,
            "title": "Discussion"
        },
        {
            "endOffset": 43482,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0090",
            "sentence": "With respect to linearity, both antibodies showed high R2 values: for 1G5, R2 was 0.9936 \u00b1 0.0113, and for 2C12, R2 was 0.9937 \u00b1 0.0104.",
            "startOffset": 43346,
            "title": "ELISA with standard HA antigens"
        },
        {
            "endOffset": 46206,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0085": {
                    "endOffset": 46205,
                    "startOffset": 46201
                }
            },
            "secId": "s0100",
            "sentence": "The concentrations of antigens were calculated using slope-ratio model with two replicates, following the guidelines from European pharmacopoeia 5.0 [17].",
            "startOffset": 46052,
            "title": "Comparison between SRID and ELISA"
        },
        {
            "endOffset": 45761,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0100",
            "sentence": "A test antigen (standard HA antigen of A/Singapore/GP1908/2015 IBR-180) was quantified by SRID, currently the recommended standardized assay, and the ELISA using the universal mAbs introduced in this study, for comparison (Fig. 7).",
            "startOffset": 45530,
            "title": "Comparison between SRID and ELISA"
        },
        {
            "endOffset": 35738,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0045": {
                    "endOffset": 35737,
                    "startOffset": 35731
                },
                "b0095": {
                    "endOffset": 35737,
                    "startOffset": 35731
                }
            },
            "secId": "s0070",
            "sentence": "RIDs of eukaryotic origin can function as a transducer for RNA-mediated chaperone activity and can be used as fusion partners to expedite soluble expression of properly folded recombinant proteins [9,19].",
            "startOffset": 35534,
            "title": "Expression and purification of mRID-cHA stalk"
        },
        {
            "endOffset": 46051,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0100",
            "sentence": "For the ELISA, the antigen was treated with pretreatment buffer (pH 5.0, 200 mM DTT, 200 mM sodium acetate buffer), and ELISA was conducted as described in Section 2.8.",
            "startOffset": 45883,
            "title": "Comparison between SRID and ELISA"
        },
        {
            "endOffset": 34319,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "Briefly, a cHA stalk sequence (Fig. 1B) was produced by merging high frequency fragments of H1, H2, H5, and H9 (Supplemental Fig. S1).",
            "startOffset": 34185,
            "title": "Generation and analysis of cHA stalk"
        },
        {
            "endOffset": 30241,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Positive hybridoma clones were screened using ELISA with the mRID-cHA stalk.",
            "startOffset": 30165,
            "title": "Generation of monoclonal antibody"
        },
        {
            "endOffset": 27866,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0065": {
                    "endOffset": 27865,
                    "startOffset": 27861
                }
            },
            "secId": "s0015",
            "sentence": "The trimer structure of the cHA stalk was produced by docking the three monomer structures using ClusPro 2.0 multimer docking [13].",
            "startOffset": 27735,
            "title": "Sequence analysis for cHA stalk"
        },
        {
            "endOffset": 41736,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0085",
            "sentence": "The CV was 4.018 \u00b1 1.106% for 1G5 and 4.377 \u00b1 1.223 for 2C12.",
            "startOffset": 41675,
            "title": "ELISA with recombinant HA antigens"
        },
        {
            "endOffset": 47789,
            "parents": [],
            "secId": "s0105",
            "sentence": "However, most of these methods rely on strain-specific mAbs corresponding to the test antigen of interest.",
            "startOffset": 47683,
            "title": "Discussion"
        },
        {
            "endOffset": 48307,
            "parents": [],
            "secId": "s0105",
            "sentence": "The present approach is based on the recognition of group-specific consensus sequence of the HA stalk domain, and thus allows quantitation of a single component (group 1 HA in this case, regardless of drift or shift strains) in multi-component influenza vaccines.",
            "startOffset": 48044,
            "title": "Discussion"
        },
        {
            "endOffset": 49125,
            "parents": [],
            "refoffsets": {
                "b0185": {
                    "endOffset": 49030,
                    "startOffset": 49026
                },
                "b0190": {
                    "endOffset": 49124,
                    "startOffset": 49120
                }
            },
            "secId": "s0105",
            "sentence": "A rare case of human-to-human transmission has been documented [37], and multiple mutations that would enable circulation among mammals have been identified [38].",
            "startOffset": 48963,
            "title": "Discussion"
        },
        {
            "endOffset": 43647,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0090",
            "sentence": "In conclusion, there was a high degree of correlation between the quantity of egg-derived HA antigen and ELISA response.",
            "startOffset": 43527,
            "title": "ELISA with standard HA antigens"
        },
        {
            "endOffset": 38952,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "The highest ELISA response was observed when HA was pretreated with pre-binding under the condition of pH 5.0 and 100 mM DTT.",
            "startOffset": 38827,
            "title": "Pretreatment of HA antigens"
        },
        {
            "endOffset": 49340,
            "parents": [],
            "secId": "s0105",
            "sentence": "In this regard, a group-specific universal antibody-based HA quantification method, primarily designed for the current seasonal influenza vaccine, may, in the future, be extended to pandemic vaccines, if necessary.",
            "startOffset": 49126,
            "title": "Discussion"
        },
        {
            "endOffset": 52593,
            "parents": [],
            "secId": "s0105",
            "sentence": "The universal antibodies used in this study performed equally efficiently for traditional egg-derived vaccines and recombinant HAs produced from eukaryotic expression systems (Supplemental Figs. S4 and S5), underscoring their utility for the quantification of newly developed recombinant subunit vaccines.",
            "startOffset": 52288,
            "title": "Discussion"
        },
        {
            "endOffset": 27273,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Secondary structures were predicted by analyzing the sequences of cHA stalk, A/Puerto Rico/8/1934 (GenBank: NC_002017.1), A/California/07/2009 (GenBank: CY266191.1), A/Canada/720/05 (GenBank: DQ009917.1), A/Indonesia/5/2005 (GenBank: EU146622.1), and A/Hong Kong/1073/99 (GenBank: AJ404626.1).",
            "startOffset": 26980,
            "title": "Sequence analysis for cHA stalk"
        },
        {
            "endOffset": 44926,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0095",
            "sentence": "Both 1G5 and 2C12 bound to group 1 HA A/Singapore/GP1908/2015 IBR-180 (H1N1).",
            "startOffset": 44849,
            "title": "ELISA with quadrivalent vaccine HA antigens"
        },
        {
            "endOffset": 24571,
            "parents": [],
            "secId": "s0005",
            "sentence": "First, this method is labor-intensive, non-automated, and time-consuming.",
            "startOffset": 24498,
            "title": "Introduction"
        },
        {
            "endOffset": 35069,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "We found no significant difference between the deduced cHA stalk and naturally occurring HA from A/Puerto Rico/8/34 (H1N1).",
            "startOffset": 34946,
            "title": "Generation and analysis of cHA stalk"
        },
        {
            "endOffset": 30033,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0080": {
                    "endOffset": 30004,
                    "startOffset": 30000
                }
            },
            "secId": "s0025",
            "sentence": "Murine mAbs against the mRID-cHA stalk for group 1 IAV were generated by murine cell fusion/hybridoma [16], by ATGEN (Seongnam, Korea).",
            "startOffset": 29898,
            "title": "Generation of monoclonal antibody"
        },
        {
            "endOffset": 32429,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0040",
            "sentence": "The enzymatic reaction was terminated by adding 0.2 N H2SO4.",
            "startOffset": 32369,
            "title": "Indirect ELISA"
        },
        {
            "endOffset": 25109,
            "parents": [],
            "refoffsets": {
                "b0035": {
                    "endOffset": 25108,
                    "startOffset": 25105
                }
            },
            "secId": "s0005",
            "sentence": "Moreover, non-availability or shortage of the reagents critically hinders vaccine supply, as exemplified by the 2009 pandemic [7].",
            "startOffset": 24979,
            "title": "Introduction"
        },
        {
            "endOffset": 31607,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0035",
            "sentence": "DTT and urea were dissolved to desired concentration after the pH was adjusted.",
            "startOffset": 31528,
            "title": "Antigen pretreatment"
        },
        {
            "endOffset": 52918,
            "parents": [],
            "refoffsets": {
                "b0240": {
                    "endOffset": 52917,
                    "startOffset": 52910
                },
                "b0245": {
                    "endOffset": 52917,
                    "startOffset": 52910
                },
                "b0250": {
                    "endOffset": 52917,
                    "startOffset": 52910
                }
            },
            "secId": "s0105",
            "sentence": "The current approach for cross-protection is to redirect the antibody responses from the variable HA globular domain to the conserved HA stalk domain [48\u201350].",
            "startOffset": 52760,
            "title": "Discussion"
        },
        {
            "endOffset": 30164,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "In brief, six-weak-old BALB/c mice were immunized twice with the mRID-cHA stalk mixed with Freund\u2019s adjuvant once every two weeks.",
            "startOffset": 30034,
            "title": "Generation of monoclonal antibody"
        },
        {
            "endOffset": 40890,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0085",
            "sentence": "Detailed results are presented in Table S4.",
            "startOffset": 40847,
            "title": "ELISA with recombinant HA antigens"
        },
        {
            "endOffset": 24237,
            "parents": [],
            "refoffsets": {
                "b0010": {
                    "endOffset": 24181,
                    "startOffset": 24178
                },
                "b0015": {
                    "endOffset": 24236,
                    "startOffset": 24231
                },
                "b0020": {
                    "endOffset": 24236,
                    "startOffset": 24231
                }
            },
            "secId": "s0005",
            "sentence": "The quantity of hemagglutinin (HA), the major protective antigen responsible for inducing neutralization antibodies [2], is related to the potency of influenza vaccines [3,4].",
            "startOffset": 24062,
            "title": "Introduction"
        },
        {
            "endOffset": 43966,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0090",
            "sentence": "Again, the affinity to H9 subtype was much lower than that of other HAs, extending the results from recombinant HAs (Supplemental Table 4).",
            "startOffset": 43827,
            "title": "ELISA with standard HA antigens"
        },
        {
            "endOffset": 24497,
            "parents": [],
            "secId": "s0005",
            "sentence": "However, because of inherent shortcomings of this method, there is an increasing demand for an alternative potency assay.",
            "startOffset": 24376,
            "title": "Introduction"
        },
        {
            "endOffset": 36376,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "In contrast, cHA stalk without fusion was expressed at a very low level, predominantly as insoluble form, at both temperatures (Fig. 2C).",
            "startOffset": 36239,
            "title": "Expression and purification of mRID-cHA stalk"
        },
        {
            "endOffset": 53543,
            "parents": [],
            "secId": "s0105",
            "sentence": "Based on a limited set of experiments, this method was proven to be more sensitive, reliable, accurate, and convenient than the current SRID method.",
            "startOffset": 53395,
            "title": "Discussion"
        },
        {
            "endOffset": 33751,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0085": {
                    "endOffset": 33750,
                    "startOffset": 33746
                }
            },
            "secId": "s0050",
            "sentence": "The test HA antigen concentration was calculated by the slope ratio method [17].",
            "startOffset": 33671,
            "title": "Quantification of HA antigens by ELISA"
        },
        {
            "endOffset": 50284,
            "parents": [],
            "secId": "s0105",
            "sentence": "Stalk domain exposure is essential to ensure full mAb binding and a subsequent ELISA response.",
            "startOffset": 50190,
            "title": "Discussion"
        },
        {
            "endOffset": 41459,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0085",
            "sentence": "The variations in ELISA response among different strains may be due to sequence variations or slight structural differences in the target epitope(s).",
            "startOffset": 41310,
            "title": "ELISA with recombinant HA antigens"
        },
        {
            "endOffset": 37323,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0110": {
                    "endOffset": 37322,
                    "startOffset": 37318
                }
            },
            "secId": "s0080",
            "sentence": "HA undergoes a conformational transition at low pH, where the stalk region becomes unmasked by the HA1 domain, forming an extended alpha helix [22].",
            "startOffset": 37175,
            "title": "Pretreatment of HA antigens"
        },
        {
            "endOffset": 28099,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0070": {
                    "endOffset": 28098,
                    "startOffset": 28091
                },
                "b0075": {
                    "endOffset": 28098,
                    "startOffset": 28091
                }
            },
            "secId": "s0015",
            "sentence": "The accessibility and polarity of the cHA stalk and the HA stalk from A/Puerto Rico/8/34 H1N1 were calculated using Environment and Virtual Docking of Atoms (Syntekabio, Daejeon, Korea), based on the Shrake-Rupley algorithm [14,15].",
            "startOffset": 27867,
            "title": "Sequence analysis for cHA stalk"
        },
        {
            "endOffset": 28721,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0020",
            "sentence": "E. coli was cultured in 15 ml of Luria-Bertani (LB) medium supplemented with 1 mM ampicillin and 1 mM chloramphenicol at 37 \u00b0C or 20 \u00b0C.",
            "startOffset": 28585,
            "title": "Cloning, expression, and purification of the cHA stalk"
        },
        {
            "endOffset": 31918,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0040",
            "sentence": "Then, 5% solution of skim milk (BD Diagnostic, Franklin Lakes, NJ) was added and incubated at room temperature for 1 h for blocking.",
            "startOffset": 31786,
            "title": "Indirect ELISA"
        },
        {
            "endOffset": 50189,
            "parents": [],
            "refoffsets": {
                "b0200": {
                    "endOffset": 50188,
                    "startOffset": 50184
                }
            },
            "secId": "s0105",
            "sentence": "Second, there may exist structural differences within HA2, where the HA stalk undergoes pH-dependent conformational transition [40].",
            "startOffset": 50057,
            "title": "Discussion"
        },
        {
            "endOffset": 49425,
            "parents": [],
            "secId": "s0105",
            "sentence": "It is desirable to use a conserved domain to elicit antibodies with cross-reactivity.",
            "startOffset": 49340,
            "title": "Discussion"
        },
        {
            "endOffset": 35533,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "Ideally, the cHA stalk should be expressed as a soluble and properly folded form to elicit conformational epitope-directed mAbs.",
            "startOffset": 35405,
            "title": "Expression and purification of mRID-cHA stalk"
        },
        {
            "endOffset": 40976,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0085",
            "sentence": "Thus, there was a strong positive correlation between HA quantity and ELISA response.",
            "startOffset": 40891,
            "title": "ELISA with recombinant HA antigens"
        },
        {
            "endOffset": 25260,
            "parents": [],
            "secId": "s0005",
            "sentence": "Therefore, there is a need for an alternative method to determine influenza vaccine potency that can shorten the time of development and distribution.",
            "startOffset": 25110,
            "title": "Introduction"
        },
        {
            "endOffset": 41674,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0085",
            "sentence": "Reproducibility is represented by the coefficient of variation (CV).",
            "startOffset": 41606,
            "title": "ELISA with recombinant HA antigens"
        },
        {
            "endOffset": 44498,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0090",
            "sentence": "Considering that these egg-derived HA antigens are currently used as standard reagents for SRID assay, the present results imply that both mAb, 1G5 and 2C12, can be directly applicable to the quantification of HAs.",
            "startOffset": 44284,
            "title": "ELISA with standard HA antigens"
        },
        {
            "endOffset": 53394,
            "parents": [],
            "secId": "s0105",
            "sentence": "In summary, we developed a HA quantitative ELISA using broadly reactive group-specific universal mAbs.",
            "startOffset": 53292,
            "title": "Discussion"
        },
        {
            "endOffset": 37767,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "For instance, the responses with pH 3.5 buffer were approximately 3\u20135 times higher than those with pH 7.4 buffer.",
            "startOffset": 37654,
            "title": "Pretreatment of HA antigens"
        },
        {
            "endOffset": 39391,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "Under this condition, there was no significant difference depending on the urea concentration.",
            "startOffset": 39297,
            "title": "Pretreatment of HA antigens"
        },
        {
            "endOffset": 31527,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0035",
            "sentence": "The pH of the pretreatment buffer was adjusted based on the Henderson-Hasselbalch equation.",
            "startOffset": 31436,
            "title": "Antigen pretreatment"
        },
        {
            "endOffset": 32897,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0045",
            "sentence": "The diameters of precipitated circular zones were measured.",
            "startOffset": 32838,
            "title": "SRID assay"
        },
        {
            "endOffset": 33013,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0085": {
                    "endOffset": 32980,
                    "startOffset": 32976
                }
            },
            "secId": "s0045",
            "sentence": "The concentration of test HA antigen was calculated by the slope ratio method [17] based on duplicate SRID results.",
            "startOffset": 32898,
            "title": "SRID assay"
        },
        {
            "endOffset": 37874,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "However, there was no significant change at pH > 5.0 where conformational transition is unlikely to occur.",
            "startOffset": 37768,
            "title": "Pretreatment of HA antigens"
        },
        {
            "endOffset": 28322,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0045": {
                    "endOffset": 28272,
                    "startOffset": 28269
                }
            },
            "secId": "s0020",
            "sentence": "The pGE-RID4 vector which has RNA interaction domain of Lysyl tRNA synthetase from mouse(mRID) as fusion protein [9] was used for soluble expression of the cHA stalk.",
            "startOffset": 28156,
            "title": "Cloning, expression, and purification of the cHA stalk"
        },
        {
            "endOffset": 30832,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0030",
            "sentence": "Detailed information on the HA antigens is presented in Supplemental Tables 1\u20133.",
            "startOffset": 30752,
            "title": "Reference HA antigens for ELISA"
        },
        {
            "endOffset": 50450,
            "parents": [],
            "secId": "s0105",
            "sentence": "As such, pretreatment at low pH to induce the extended alpha-helical conformation and with DTT to dissociate and remove the HA1 domain was necessary (Figs. 4 and 5).",
            "startOffset": 50285,
            "title": "Discussion"
        },
        {
            "endOffset": 32368,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0040",
            "sentence": "Lastly, 3,3\u2032,5,5\u2032-tetramethlybenzidine substrate solution (BD Biosciences, Franklin Lakes, NJ) was added and incubated at room temperature in the dark for 30 min.",
            "startOffset": 32206,
            "title": "Indirect ELISA"
        },
        {
            "endOffset": 43110,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0090",
            "sentence": "The binding specificities were consistent with those of recombinant HA antigens (Supplemental Figs. S4 and S5).",
            "startOffset": 42999,
            "title": "ELISA with standard HA antigens"
        },
        {
            "endOffset": 42297,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0090",
            "sentence": "ELISA with the standard HA antigens were also conducted using 1G5 and 2C12 with statistical indicators in terms of linearity, sensitivity, and reproducibility (Supplemental Fig. S3).",
            "startOffset": 42115,
            "title": "ELISA with standard HA antigens"
        },
        {
            "endOffset": 46999,
            "parents": [],
            "secId": "s0105",
            "sentence": "Timely distribution of vaccines is important in preventing influenza infection among humans.",
            "startOffset": 46907,
            "title": "Discussion"
        },
        {
            "endOffset": 47422,
            "parents": [],
            "secId": "s0105",
            "sentence": "The mAbs against the consensus stalk domain exhibited group-specific universality against various subtypes within group 1 IAVs, without cross-reactivity to group 2 IAVs or IBVs.",
            "startOffset": 47245,
            "title": "Discussion"
        },
        {
            "endOffset": 41606,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0085",
            "sentence": "Moreover, the lack of H9 reference sequences at the time of consensus sequence deduction may explain, in part, the low affinity to the H9 subtype.",
            "startOffset": 41460,
            "title": "ELISA with recombinant HA antigens"
        },
        {
            "endOffset": 46390,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0100",
            "sentence": "The concentration quantified by ELISA using 1G5 was 39.92 \u00b1 1.98 \u00b5g/ml and that using 2C12 was 38.44 \u00b1 1.60 \u00b5g/ml.",
            "startOffset": 46276,
            "title": "Comparison between SRID and ELISA"
        },
        {
            "endOffset": 41084,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0085",
            "sentence": "Regarding sensitivity, the limit of detection (LOD), except for the H9 subtype, were lower than \u223c0.04 \u00b5g/ml.",
            "startOffset": 40976,
            "title": "ELISA with recombinant HA antigens"
        },
        {
            "endOffset": 50607,
            "parents": [],
            "refoffsets": {
                "b0200": {
                    "endOffset": 50606,
                    "startOffset": 50602
                }
            },
            "secId": "s0105",
            "sentence": "The pH dependence of coiled-coil structural transition at the HA2 region is influenced by the pKa value of amino acids in the inter-connecting peptide [40].",
            "startOffset": 50451,
            "title": "Discussion"
        },
        {
            "endOffset": 53292,
            "parents": [],
            "secId": "s0105",
            "sentence": "If stalk-based universal vaccines are ever developed and licensed, the present quantitative ELISA using stalk-targeting universal mAbs would provide a proper choice for potency validation.",
            "startOffset": 53104,
            "title": "Discussion"
        },
        {
            "endOffset": 37039,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0075",
            "sentence": "Also, the response curve using the mRID-cHA stalk confirmed its potential for quantitative detection of HA antigens.",
            "startOffset": 36923,
            "title": "mAb generation and validation"
        },
        {
            "endOffset": 43208,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0090",
            "sentence": "These results confirmed the specificity of 1G5 and 2C12 for multiple subtypes of group 1 IAV HAs.",
            "startOffset": 43111,
            "title": "ELISA with standard HA antigens"
        },
        {
            "endOffset": 42081,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0085",
            "sentence": "In summary, the universal mAbs, 1G5 and 2C12, are specific to multiple subtypes of HAs within group 1, without cross-reactivity to other subtypes of HA, with a high degree of linearity, sensitivity, and reproducibility.",
            "startOffset": 41862,
            "title": "ELISA with recombinant HA antigens"
        },
        {
            "endOffset": 39296,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "Finally, antigens were pretreated with various concentrations of urea under the condition of pH 5.0 and 100 mM DTT (Fig. 4M\u2013P).",
            "startOffset": 39169,
            "title": "Pretreatment of HA antigens"
        },
        {
            "endOffset": 38826,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "HA antigens were treated with buffers of various combinations of different pH and DTT concentrations pre- or post-binding (Fig. 5).",
            "startOffset": 38695,
            "title": "Pretreatment of HA antigens"
        },
        {
            "endOffset": 34184,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "The procedure for the generation and validation of consensus HA stalk for group 1 IAV is outlined in Fig. 1A and the experimental details are described in Section 2.1.",
            "startOffset": 34017,
            "title": "Generation and analysis of cHA stalk"
        },
        {
            "endOffset": 44848,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0095",
            "sentence": "The tested vaccine components for quadrivalent influenza vaccines were derived from embryonated eggs and were supplied by Green Cross Pharma (Yongin-si, Korea).",
            "startOffset": 44688,
            "title": "ELISA with quadrivalent vaccine HA antigens"
        },
        {
            "endOffset": 52076,
            "parents": [],
            "secId": "s0105",
            "sentence": "We expect our ELISA to be useful for the evaluation of new types of influenza vaccines, either licensed or under development.",
            "startOffset": 51951,
            "title": "Discussion"
        },
        {
            "endOffset": 26581,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0050": {
                    "endOffset": 26514,
                    "startOffset": 26510
                }
            },
            "secId": "s0015",
            "sentence": "First, highly conserved amino acid residues from each HA subtype were deduced using Seq2logo 2.0 [10] and Vector NTI Advance\u00ae version 11.5 (Thermo Fisher, Waltham, MA).",
            "startOffset": 26413,
            "title": "Sequence analysis for cHA stalk"
        },
        {
            "endOffset": 34945,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0090": {
                    "endOffset": 34816,
                    "startOffset": 34812
                }
            },
            "secId": "s0065",
            "sentence": "Surface accessibility and polarity, key scoring indicators for immunogenic epitopes [18], of the cHA stalk were calculated based on the trimer structure and were compared with those of viral HA (Supplemental Fig. S2).",
            "startOffset": 34728,
            "title": "Generation and analysis of cHA stalk"
        },
        {
            "endOffset": 45824,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0100",
            "sentence": "The antigens were treated with the Zwittergent 3-14 detergent.",
            "startOffset": 45762,
            "title": "Comparison between SRID and ELISA"
        },
        {
            "endOffset": 43526,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0090",
            "sentence": "Detailed results are summarized in Table 1.",
            "startOffset": 43483,
            "title": "ELISA with standard HA antigens"
        },
        {
            "endOffset": 49524,
            "parents": [],
            "refoffsets": {
                "b0195": {
                    "endOffset": 49523,
                    "startOffset": 49519
                }
            },
            "secId": "s0105",
            "sentence": "HA is composed of a highly variable HA1 globular domain and a relatively conserved HA2 stalk [39].",
            "startOffset": 49426,
            "title": "Discussion"
        },
        {
            "endOffset": 44101,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0090",
            "sentence": "Regarding the reproducibility, The CV was 3.962 \u00b1 0.824% for 1G5 and 4.268 \u00b1 1.004 for 2C12 (Table 1), indicating high reproducibility.",
            "startOffset": 43966,
            "title": "ELISA with standard HA antigens"
        },
        {
            "endOffset": 25598,
            "parents": [],
            "secId": "s0005",
            "sentence": "We analyzed the conserved domain of the HA stalk to design a consensus HA (cHA) stalk for group 1 influenza A viruses (IAVs).",
            "startOffset": 25473,
            "title": "Introduction"
        },
        {
            "endOffset": 46275,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0100",
            "sentence": "The concentration of HA as quantified by SRID was 36.53 \u00b1 2.97 \u00b5g/ml.",
            "startOffset": 46206,
            "title": "Comparison between SRID and ELISA"
        },
        {
            "endOffset": 36480,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "Thus, mRID-cHA stalk (\u223c30 kDa) produced at 20 \u00b0C was purified by Ni+ affinity chromatography (Fig. 2D).",
            "startOffset": 36377,
            "title": "Expression and purification of mRID-cHA stalk"
        },
        {
            "endOffset": 43742,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0090",
            "sentence": "In terms of sensitivity, the LOD values of HAs (except H9 subtype) were lower than \u223c0.05 \u00b5g/ml.",
            "startOffset": 43647,
            "title": "ELISA with standard HA antigens"
        },
        {
            "endOffset": 46813,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0100",
            "sentence": "In summary, subjected to the limited availability of commercial sample materials, the quantitative ELISA using antibodies against the consensus stalk domain is found comparable to SRID with respect to its determined concentration.",
            "startOffset": 46583,
            "title": "Comparison between SRID and ELISA"
        },
        {
            "endOffset": 37562,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "First, low-pH solutions were used for antigen pretreatments (Fig. 4A\u2013D).",
            "startOffset": 37490,
            "title": "Pretreatment of HA antigens"
        },
        {
            "endOffset": 44687,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0095",
            "sentence": "Finally, the ELISA was extended to commercial influenza vaccine antigens (Fig. 6), with relevant statistical indicators (Supplemental Table 5).",
            "startOffset": 44544,
            "title": "ELISA with quadrivalent vaccine HA antigens"
        },
        {
            "endOffset": 23735,
            "parents": [],
            "refoffsets": {
                "b0005": {
                    "endOffset": 23734,
                    "startOffset": 23731
                }
            },
            "secId": "s0005",
            "sentence": "Seasonal and pandemic influenza infections remain a serious public health concern [1].",
            "startOffset": 23649,
            "title": "Introduction"
        },
        {
            "endOffset": 51951,
            "parents": [],
            "secId": "s0105",
            "sentence": "The concentrations of HA determined by ELISA were similar to those determined by SRID (Fig. 7).",
            "startOffset": 51856,
            "title": "Discussion"
        },
        {
            "endOffset": 33281,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0050",
            "sentence": "The test HA antigen was a component of quadrivalent influenza vaccine (GC flu) (kindly supplied by Green Cross Co., Korea).",
            "startOffset": 33158,
            "title": "Quantification of HA antigens by ELISA"
        },
        {
            "endOffset": 39468,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "Likely, low pH and reducing condition are sufficient to expose the HA stalk.",
            "startOffset": 39392,
            "title": "Pretreatment of HA antigens"
        },
        {
            "endOffset": 29655,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0020",
            "sentence": "Each fraction was analyzed by SDS-PAGE, and the fractions enriched in mRID-cHA stalk were pooled, dialyzed against storage buffer (50 mM Tris-Cl (pH 7.5), 100 mM NaCl, 0.1 mM EDTA, 0.1% Tween-20), and concentrated using Centriprep\u00ae centrifugal filter (Merck Millipore, Burlington, MA).",
            "startOffset": 29370,
            "title": "Cloning, expression, and purification of the cHA stalk"
        },
        {
            "endOffset": 51855,
            "parents": [],
            "secId": "s0105",
            "sentence": "LOD values for all ELISAs were lower than that for SRID, which are usually 3\u20135 \u00b5g/ml, and CVs were less than 5%.",
            "startOffset": 51743,
            "title": "Discussion"
        },
        {
            "endOffset": 24660,
            "parents": [],
            "refoffsets": {
                "b0030": {
                    "endOffset": 24659,
                    "startOffset": 24656
                }
            },
            "secId": "s0005",
            "sentence": "Second, because of its low sensitivity, it requires high concentrations of antigens [6].",
            "startOffset": 24572,
            "title": "Introduction"
        },
        {
            "endOffset": 48527,
            "parents": [],
            "refoffsets": {
                "b0150": {
                    "endOffset": 48526,
                    "startOffset": 48522
                }
            },
            "secId": "s0105",
            "sentence": "Among these, H1 subtype virus has been circulating in the human population over the last century [30].",
            "startOffset": 48425,
            "title": "Discussion"
        },
        {
            "endOffset": 36858,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0075",
            "sentence": "The two clones bound to the mRID-cHA stalk, but not to mRID.",
            "startOffset": 36798,
            "title": "mAb generation and validation"
        },
        {
            "endOffset": 51074,
            "parents": [],
            "refoffsets": {
                "b0210": {
                    "endOffset": 51073,
                    "startOffset": 51069
                }
            },
            "secId": "s0105",
            "sentence": "Notably, the quantification of international standards from NIBSC is based on quantitative SDS-PAGE [42].",
            "startOffset": 50969,
            "title": "Discussion"
        },
        {
            "endOffset": 24873,
            "parents": [],
            "secId": "s0005",
            "sentence": "Third, it depends on strain-specific standard reagents, purified viral HA antigen, and polyclonal anti-serum, which take two to three months to produce and are distributed only by a few WHO collaborating centers.",
            "startOffset": 24661,
            "title": "Introduction"
        },
        {
            "endOffset": 29862,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0020",
            "sentence": "The concentration of the antigen was determined by PAGE followed by densitometric quantitation of the coomassie-stained protein band using bovine serum albumin (Amresco, Solon, OH) with known concentration.",
            "startOffset": 29656,
            "title": "Cloning, expression, and purification of the cHA stalk"
        },
        {
            "endOffset": 32837,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0045",
            "sentence": "The standard HA antigen of A/Singapore/GP1908/2015 (IVR-180) (NIBSC product number: 16/292) and the corresponding standard anti-A/Michigan/45/2015-like HA serum (NIBSC product number: 16/304) were used.",
            "startOffset": 32635,
            "title": "SRID assay"
        },
        {
            "endOffset": 36056,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "Expression of mRID-cHA stalk was induced at various temperatures.",
            "startOffset": 35991,
            "title": "Expression and purification of mRID-cHA stalk"
        },
        {
            "endOffset": 26979,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0055": {
                    "endOffset": 26978,
                    "startOffset": 26974
                }
            },
            "secId": "s0015",
            "sentence": "Secondary structure prediction was conducted using Network Protein Sequence in ExPASy [11].",
            "startOffset": 26888,
            "title": "Sequence analysis for cHA stalk"
        },
        {
            "endOffset": 41237,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0085",
            "sentence": "However, the LOD values varied depending on the strain, probably reflecting differences in the affinity of the antibodies to HAs from different strains.",
            "startOffset": 41085,
            "title": "ELISA with recombinant HA antigens"
        },
        {
            "endOffset": 23804,
            "parents": [],
            "secId": "s0005",
            "sentence": "Annual vaccination is recommended by many public health authorities.",
            "startOffset": 23736,
            "title": "Introduction"
        },
        {
            "endOffset": 39793,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0085",
            "sentence": "ELISAs with recombinant HA antigens produced from human cells or insect cells were conducted using the antibodies 1G5 and 2C12 (Supplemental Fig. S3).",
            "startOffset": 39643,
            "title": "ELISA with recombinant HA antigens"
        },
        {
            "endOffset": 47682,
            "parents": [],
            "refoffsets": {
                "b0130": {
                    "endOffset": 47681,
                    "startOffset": 47674
                },
                "b0135": {
                    "endOffset": 47681,
                    "startOffset": 47674
                },
                "b0140": {
                    "endOffset": 47681,
                    "startOffset": 47674
                }
            },
            "secId": "s0105",
            "sentence": "As an alternative to SRID, various HA quantification assays using mAbs have been developed [26\u201328].",
            "startOffset": 47583,
            "title": "Discussion"
        },
        {
            "endOffset": 38694,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "A potential synergistic effect between low pH and DTT was also tested.",
            "startOffset": 38624,
            "title": "Pretreatment of HA antigens"
        },
        {
            "endOffset": 50876,
            "parents": [],
            "refoffsets": {
                "b0205": {
                    "endOffset": 50756,
                    "startOffset": 50752
                }
            },
            "secId": "s0105",
            "sentence": "Third, secondary modification (e.g., glycosylation) of HA depends on the production host (mammalian, insect cells, or embryonated chicken eggs) [41], and the quality or extent of glycosylation, especially in the vicinity of the HA2 domain, may affect ELISA reactivity.",
            "startOffset": 50608,
            "title": "Discussion"
        },
        {
            "endOffset": 38411,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "PBS (pH 7.4) containing DTT at different concentrations was used for antigen pretreatments pre- and post-binding (Fig. 4E\u2013H).",
            "startOffset": 38286,
            "title": "Pretreatment of HA antigens"
        },
        {
            "endOffset": 48809,
            "parents": [],
            "refoffsets": {
                "b0165": {
                    "endOffset": 48808,
                    "startOffset": 48801
                },
                "b0170": {
                    "endOffset": 48808,
                    "startOffset": 48801
                }
            },
            "secId": "s0105",
            "sentence": "However, there remains a possibility of re-introduction of H2 subtype strains by zoonotic transmission from birds and swine [33,34].",
            "startOffset": 48677,
            "title": "Discussion"
        },
        {
            "endOffset": 46582,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0100",
            "sentence": "Of note, error ranges from ELISA were smaller than those of SRID.",
            "startOffset": 46517,
            "title": "Comparison between SRID and ELISA"
        },
        {
            "endOffset": 48962,
            "parents": [],
            "refoffsets": {
                "b0175": {
                    "endOffset": 48961,
                    "startOffset": 48954
                },
                "b0180": {
                    "endOffset": 48961,
                    "startOffset": 48954
                }
            },
            "secId": "s0105",
            "sentence": "The H5 subtype can cause fatal infection in humans as exemplified by the avian-human transmission of the highly pathogenic avian influenza H5N1 [35,36].",
            "startOffset": 48810,
            "title": "Discussion"
        },
        {
            "endOffset": 50968,
            "parents": [],
            "secId": "s0105",
            "sentence": "Finally, variations among HA quantification assays of different vendors cannot be excluded.",
            "startOffset": 50877,
            "title": "Discussion"
        },
        {
            "endOffset": 36688,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0080": {
                    "endOffset": 36687,
                    "startOffset": 36683
                }
            },
            "secId": "s0075",
            "sentence": "mAbs were generated by hybridoma fusion [16].",
            "startOffset": 36643,
            "title": "mAb generation and validation"
        },
        {
            "endOffset": 53851,
            "parents": [],
            "secId": "s0105",
            "sentence": "The assay is currently being extended to group 2 IAV and IBVs, and if successful, would serve as the evaluation of the potency of trivalent and quadrivalent influenza vaccines.",
            "startOffset": 53675,
            "title": "Discussion"
        },
        {
            "endOffset": 24978,
            "parents": [],
            "secId": "s0005",
            "sentence": "These reagents are crucially important for timely release of vaccines to the public by annual licensure.",
            "startOffset": 24874,
            "title": "Introduction"
        },
        {
            "endOffset": 40400,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0085",
            "sentence": "Both antibodies could bind with group 1 IAV HAs, including H1 subtype (A/California/07/2009, A/Puerto Rico/8/34, A/New Caledonia/20/99, A/Brisbane/59/2007), H2 subtype (A/Canada/720/2005, A/Japan/305/1957), H5 subtype (A/Indonesia/5/2005, A/American green-winged teal/California/HKWF609/2007), and H9 subtype (A/duck/NZL/76/1984, A/Hong Kong/1073/99), but not with group 2 IAV HAs, including H3 subtype (A/Texas/50/2012, A/Brisbane/10/2007) and H7 subtype (A/Netherlands/219/03), nor with B virus HAs including B/Phuket/3073/2013, B/Yamagata/16/1988 and B/Massachusetts/03/2010 (Supplemental Figs. S4, S5).",
            "startOffset": 39794,
            "title": "ELISA with recombinant HA antigens"
        },
        {
            "endOffset": 36238,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0100": {
                    "endOffset": 36237,
                    "startOffset": 36233
                }
            },
            "secId": "s0070",
            "sentence": "Induction at 20 \u00b0C resulted in relatively higher solubility (\u223c40%) than induction at 37 \u00b0C (\u223c20%), as analyzed by SDS-PAGE (Fig. 2B), probably due to a lower translation speed [20].",
            "startOffset": 36057,
            "title": "Expression and purification of mRID-cHA stalk"
        },
        {
            "endOffset": 47244,
            "parents": [],
            "secId": "s0105",
            "sentence": "Here, we introduced a novel ELISA using antibodies that can bind to HA of various strains.",
            "startOffset": 47154,
            "title": "Discussion"
        },
        {
            "endOffset": 28951,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0020",
            "sentence": "Total cell lysates and each fraction were analyzed by SDS-PAGE.",
            "startOffset": 28888,
            "title": "Cloning, expression, and purification of the cHA stalk"
        },
        {
            "endOffset": 23911,
            "parents": [],
            "secId": "s0005",
            "sentence": "Ensuring optimal vaccine potency is important for timely release of vaccine lots in a reproducible manner.",
            "startOffset": 23805,
            "title": "Introduction"
        },
        {
            "endOffset": 28584,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0020",
            "sentence": "The E. coli strain BL21 star (DE3) pLysS (Invitrogen, Carlsbad, CA) was used for recombinant protein expression.",
            "startOffset": 28472,
            "title": "Cloning, expression, and purification of the cHA stalk"
        },
        {
            "endOffset": 42998,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0090",
            "sentence": "Both antibodies bound specifically with the group 1 IAV HAs of H1 subtype (A/Michigan/45/2015 (NYMC X-275), A/Singapore/GP1908/2015 (IVR-180), A/California/7/09 (NYMC-X181), A/Puerto Rico/8/34, A/Brisbane/59/2007 (IVR-148)), H2 subtype (A/Singapore/1/57), H5 subtype (A/Anhui/1/05 IBCDC-RG-6), and H9 subtype (A/chick/Hong Kong/G9/1997 NIBRG-91), but not with group 2 IAV HAs of H3 subtype (A/Hong Kong/4801/2014 (NYMC X-263B), A/Switzerland/9715293/2013 (NIB88), A/Texas/50/2012 (NYMC X-223A)), nor with B virus HAs of B/Brisbane/60/2008 (NYMC BX-35), B/Phuket/3073/2013 and B/Massachusetts/02/2012 (Supplemental Figs. S6 and S7).",
            "startOffset": 42367,
            "title": "ELISA with standard HA antigens"
        },
        {
            "endOffset": 24061,
            "parents": [],
            "secId": "s0005",
            "sentence": "For this purpose, regulatory guidelines ask vaccine manufacturers to strictly supervise the potency at the time of release and throughout shelf-life.",
            "startOffset": 23912,
            "title": "Introduction"
        },
        {
            "endOffset": 28887,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0020",
            "sentence": "After centrifugation, the pelleted cells were resuspended in phosphate-buffered saline (PBS), sonicated, and centrifuged to separate soluble and insoluble fractions.",
            "startOffset": 28722,
            "title": "Cloning, expression, and purification of the cHA stalk"
        },
        {
            "endOffset": 40683,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0085",
            "sentence": "Statistical analysis based on linear regression were implemented to validate the ELISA results with respect to linearity, sensitivity, and reproducibility (Supplemental Table 4).",
            "startOffset": 40505,
            "title": "ELISA with recombinant HA antigens"
        },
        {
            "endOffset": 41309,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0085",
            "sentence": "Specially, the H9 subtype had lower affinity than the other HAs tested.",
            "startOffset": 41238,
            "title": "ELISA with recombinant HA antigens"
        },
        {
            "endOffset": 50056,
            "parents": [],
            "secId": "s0105",
            "sentence": "First, there could be slight sequence variation in the test HA antigens, which may affect the mAb binding affinity.",
            "startOffset": 49941,
            "title": "Discussion"
        }
    ],
    "docId": "S0264410X19301537",
    "metadata": {
        "asjc": [
            "1313",
            "2400",
            "2725",
            "2739",
            "3400"
        ],
        "authors": [
            {
                "email": null,
                "first": "Wonil",
                "initial": "W.",
                "last": "Chae"
            },
            {
                "email": null,
                "first": "Paul",
                "initial": "P.",
                "last": "Kim"
            },
            {
                "email": null,
                "first": "Beom Jeung",
                "initial": "B.J.",
                "last": "Hwang"
            },
            {
                "email": "blseong@yonsei.ac.kr",
                "first": "Baik Lin",
                "initial": "B.L.",
                "last": "Seong"
            }
        ],
        "doi": "10.1016/j.vaccine.2019.01.068",
        "firstpage": "1457",
        "issn": "0264410X",
        "keywords": [
            "Consensus HA",
            "ELISA",
            "Influenza vaccine",
            "Potency test",
            "RNA-mediated chaperone",
            "Universal antibodies"
        ],
        "lastpage": "1466",
        "openaccess": "Full",
        "pub_year": 2019,
        "subjareas": [
            "BIOC",
            "IMMU",
            "MEDI",
            "VETE"
        ],
        "title": "Universal monoclonal antibody-based influenza hemagglutinin quantitative enzyme-linked immunosorbent assay"
    }
}